| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | CCT3 KIF1A CFTR DDX42 ABCB1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A | 3.63e-07 | 441 | 260 | 21 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | CCT3 KIF1A CFTR DDX42 ABCB1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 IPO8 MYO1B CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A | 6.04e-06 | 614 | 260 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 8.63e-06 | 11 | 260 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium ion binding | TTYH1 DCHS2 TBC1D9B CDHR2 FAT1 CDH20 HMCN2 TCHHL1 CABP4 PADI1 CRACR2A ESYT1 PCDHGA3 PCDH11Y CLSTN1 ARSA HMCN1 PLCH2 SLC25A13 MACF1 RAPGEF2 ATP2A1 PCDHGC3 AGRN CDH13 | 1.71e-05 | 749 | 260 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | RNA helicase activity | 7.04e-05 | 78 | 260 | 7 | GO:0003724 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L CCT3 KIF1A CFTR DDX42 ABCB1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 CRACR2A CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A MX2 | 8.23e-05 | 775 | 260 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 8.28e-05 | 80 | 260 | 7 | GO:0008186 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L CCT3 KIF1A CFTR DDX42 ABCB1 PRUNE1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 CRACR2A CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A MX2 | 1.07e-04 | 839 | 260 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L CCT3 KIF1A CFTR DDX42 ABCB1 PRUNE1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 CRACR2A CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A MX2 | 1.09e-04 | 840 | 260 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L CCT3 KIF1A CFTR DDX42 ABCB1 PRUNE1 ATP2C2 KIF19 DDX54 NAV1 DDX23 DDX43 ATP13A4 CRACR2A CHD7 UPF1 ATP10A MACF1 DDX21 ATP2A1 ATP2A3 SNRNP200 ATP5F1A MX2 | 1.09e-04 | 840 | 260 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDHR2 OBSCN DBN1 ITGB4 CDH20 PI4KA DMD GCN1 STK24 CNTN1 TNC RTN4 LAMA5 LAMB2 MYO1B POSTN KIRREL1 MACF1 CDH13 | 3.42e-04 | 599 | 260 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.64e-04 | 109 | 260 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.26e-04 | 188 | 260 | 9 | GO:0005201 | |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB3 KIF1A SARM1 DBN1 NPHP4 ITGB4 SLITRK1 MAGI2 CDH20 HMCN2 NFATC4 PKHD1 SDC4 STON1 ANK2 TNC RTN4 LAMA5 LAMB2 CLSTN1 SLC1A1 HDAC7 SPTBN4 KIRREL1 MACF1 RAPGEF2 PCDHGC3 AGRN CDH13 | 1.06e-05 | 974 | 254 | 29 | GO:0034330 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDHR2 FAT1 CDH20 HMCN2 PCDHGA3 PCDH11Y CLSTN1 HMCN1 PCDHGC3 CDH13 | 2.15e-05 | 187 | 254 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | neuron development | GABRB3 EPOR NMNAT2 KIF1A SARM1 KATNB1 DBN1 PTCH1 NPHP4 SLITRK1 MAGI2 HMCN2 NFATC4 CABP4 DENND5A DMD STK24 SDC4 CNTN1 CARM1 SLC4A7 SZT2 TNC SYNE1 RTN4 SCYL3 LAMA5 LAMB2 ZMIZ1 SPTBN4 POSTN LLGL1 FEZ2 MACF1 RAPGEF2 AGRN OTOG | 2.36e-05 | 1463 | 254 | 37 | GO:0048666 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 EPPK1 LAYN CDHR2 OBSCN DBN1 NPHP4 ITGB4 ABCB1 PRUNE1 MAGI2 NPHS2 FAT1 CDH20 PIK3R2 PI4KA SYNE2 DMD SDC4 ARHGEF6 ANK2 TNC RTN4 PRX AKAP12 SPTBN4 LLGL1 HMCN1 LAMTOR3 KIRREL1 DCTN4 RAPGEF2 PCDHGC3 CDH13 | 5.36e-08 | 976 | 259 | 34 | GO:0070161 |
| GeneOntologyCellularComponent | axon | GABRB3 TTYH1 CNTNAP3B NMNAT2 KIF1A SARM1 KATNB1 CNTNAP3 DBN1 PTCH1 HMCN2 CABP4 NAV1 DMD CNTN1 AMPH CAD SLC4A8 TPRG1L PNMT HCN4 HCN3 SLC1A1 SPTBN4 LLGL1 FEZ2 AGRN | 1.80e-05 | 891 | 259 | 27 | GO:0030424 |
| GeneOntologyCellularComponent | cell-substrate junction | EPPK1 LAYN ITGB4 PRUNE1 FAT1 PIK3R2 PI4KA SYNE2 DMD SDC4 TNC AKAP12 HMCN1 LAMTOR3 DCTN4 CDH13 | 1.41e-04 | 443 | 259 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | basement membrane | 1.42e-04 | 122 | 259 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | MAGI2 CDH20 PIK3R2 GML MCF2L AMPH TEPSIN TPRG1L ANK2 ARSA CDH13 | 1.47e-04 | 230 | 259 | 11 | GO:0019898 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 EPPK1 OBSCN DBN1 NPHP4 ABCB1 MAGI2 NPHS2 FAT1 CDH20 ARHGEF6 ANK2 SPTBN4 LLGL1 HMCN1 KIRREL1 RAPGEF2 PCDHGC3 CDH13 | 1.55e-04 | 591 | 259 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | neuron projection terminus | GABRB3 CABP4 DMD AMPH CAD SLC4A8 TPRG1L PNMT HCN4 HCN3 SLC1A1 | 1.65e-04 | 233 | 259 | 11 | GO:0044306 |
| GeneOntologyCellularComponent | axon terminus | 3.04e-04 | 210 | 259 | 10 | GO:0043679 | |
| GeneOntologyCellularComponent | laminin-11 complex | 4.55e-04 | 3 | 259 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | trans-Golgi network | NMNAT2 CNST COG3 ATP2C2 DENND5A YIPF6 TEPSIN CRACR2A MYO1B POSTN LLGL1 DOP1A | 4.62e-04 | 306 | 259 | 12 | GO:0005802 |
| GeneOntologyCellularComponent | synaptic cleft | 7.10e-04 | 33 | 259 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | HCN channel complex | 9.03e-04 | 4 | 259 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | KICSTOR complex | 9.03e-04 | 4 | 259 | 2 | GO:0140007 | |
| GeneOntologyCellularComponent | distal axon | GABRB3 KATNB1 DBN1 PTCH1 CABP4 AMPH CAD SLC4A8 TPRG1L PNMT HCN4 HCN3 SLC1A1 AGRN | 1.12e-03 | 435 | 259 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | terminal bouton | 1.25e-03 | 96 | 259 | 6 | GO:0043195 | |
| Domain | Spectrin | 5.19e-07 | 23 | 256 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 2.28e-06 | 29 | 256 | 6 | IPR002017 | |
| Domain | CA | DCHS2 CDHR2 FREM2 FAT1 CDH20 PCDHGA3 PCDH11Y CLSTN1 PCDHGC3 CDH13 | 4.15e-06 | 115 | 256 | 10 | SM00112 |
| Domain | SPEC | 4.20e-06 | 32 | 256 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.20e-06 | 32 | 256 | 6 | IPR018159 | |
| Domain | Cadherin | DCHS2 CDHR2 FREM2 FAT1 CDH20 PCDHGA3 PCDH11Y CLSTN1 PCDHGC3 CDH13 | 5.23e-06 | 118 | 256 | 10 | IPR002126 |
| Domain | ACTININ_2 | 1.28e-05 | 23 | 256 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.28e-05 | 23 | 256 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.28e-05 | 23 | 256 | 5 | IPR001589 | |
| Domain | CADHERIN_1 | 2.56e-05 | 113 | 256 | 9 | PS00232 | |
| Domain | Cadherin | 2.56e-05 | 113 | 256 | 9 | PF00028 | |
| Domain | - | 2.75e-05 | 114 | 256 | 9 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 2.75e-05 | 114 | 256 | 9 | PS50268 | |
| Domain | Cadherin-like | 3.16e-05 | 116 | 256 | 9 | IPR015919 | |
| Domain | DEAD_ATP_HELICASE | 5.91e-05 | 31 | 256 | 5 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 8.07e-05 | 33 | 256 | 5 | IPR000629 | |
| Domain | Cation_ATPase_N | 9.07e-05 | 18 | 256 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 9.07e-05 | 18 | 256 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cyto_domN | 1.08e-04 | 35 | 256 | 5 | IPR023299 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.14e-04 | 19 | 256 | 4 | IPR004014 | |
| Domain | ATPase_P-typ_P_site | 1.24e-04 | 36 | 256 | 5 | IPR018303 | |
| Domain | P_typ_ATPase | 1.24e-04 | 36 | 256 | 5 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.24e-04 | 36 | 256 | 5 | PS00154 | |
| Domain | Cadherin_CS | 1.29e-04 | 109 | 256 | 8 | IPR020894 | |
| Domain | Laminin_G | 1.39e-04 | 58 | 256 | 6 | IPR001791 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.42e-04 | 37 | 256 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.42e-04 | 37 | 256 | 5 | PF00122 | |
| Domain | Q_MOTIF | 1.42e-04 | 37 | 256 | 5 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.42e-04 | 37 | 256 | 5 | IPR014014 | |
| Domain | LAM_G_DOMAIN | 1.61e-04 | 38 | 256 | 5 | PS50025 | |
| Domain | CH | 2.63e-04 | 65 | 256 | 6 | SM00033 | |
| Domain | Hydrolase_3 | 2.84e-04 | 10 | 256 | 3 | PF08282 | |
| Domain | LamG | 3.27e-04 | 44 | 256 | 5 | SM00282 | |
| Domain | CH | 3.94e-04 | 70 | 256 | 6 | PF00307 | |
| Domain | - | 4.25e-04 | 71 | 256 | 6 | 1.10.418.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.94e-04 | 73 | 256 | 6 | IPR011545 | |
| Domain | CH | 4.94e-04 | 73 | 256 | 6 | PS50021 | |
| Domain | DEAD | 4.94e-04 | 73 | 256 | 6 | PF00270 | |
| Domain | P-type_ATPase_IIA | 5.56e-04 | 3 | 256 | 2 | IPR005782 | |
| Domain | CH-domain | 5.71e-04 | 75 | 256 | 6 | IPR001715 | |
| Domain | Helicase_C | 6.81e-04 | 107 | 256 | 7 | PF00271 | |
| Domain | HELICc | 6.81e-04 | 107 | 256 | 7 | SM00490 | |
| Domain | Helicase_C | 7.20e-04 | 108 | 256 | 7 | IPR001650 | |
| Domain | HAD-like_dom | 7.54e-04 | 79 | 256 | 6 | IPR023214 | |
| Domain | DEXDc | 7.61e-04 | 109 | 256 | 7 | SM00487 | |
| Domain | HELICASE_CTER | 7.61e-04 | 109 | 256 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.61e-04 | 109 | 256 | 7 | PS51192 | |
| Domain | Helicase_ATP-bd | 8.03e-04 | 110 | 256 | 7 | IPR014001 | |
| Domain | ARM-type_fold | STK36 SARM1 INTS1 PI4KA GCN1 IPO8 SCYL3 ARMC10 CWC22 PPP4R4 IPO9 LTN1 INTS4 | 8.51e-04 | 339 | 256 | 13 | IPR016024 |
| Domain | - | 9.17e-04 | 32 | 256 | 4 | 3.40.1110.10 | |
| Domain | - | 9.17e-04 | 32 | 256 | 4 | 2.70.150.10 | |
| Domain | KASH | 1.10e-03 | 4 | 256 | 2 | PS51049 | |
| Domain | NIDOGEN_G2 | 1.10e-03 | 4 | 256 | 2 | PS50993 | |
| Domain | KASH | 1.10e-03 | 4 | 256 | 2 | PF10541 | |
| Domain | G2_nidogen/fibulin_G2F | 1.10e-03 | 4 | 256 | 2 | IPR006605 | |
| Domain | KASH | 1.10e-03 | 4 | 256 | 2 | IPR012315 | |
| Domain | G2F | 1.10e-03 | 4 | 256 | 2 | PF07474 | |
| Domain | Ion_trans_N | 1.10e-03 | 4 | 256 | 2 | IPR013621 | |
| Domain | KASH | 1.10e-03 | 4 | 256 | 2 | SM01249 | |
| Domain | GFP | 1.10e-03 | 4 | 256 | 2 | IPR009017 | |
| Domain | Ion_trans_N | 1.10e-03 | 4 | 256 | 2 | PF08412 | |
| Domain | ATPase_P-typ_TM_dom | 1.25e-03 | 16 | 256 | 3 | IPR023298 | |
| Domain | UDENN | 1.25e-03 | 16 | 256 | 3 | PS50946 | |
| Domain | DDENN | 1.25e-03 | 16 | 256 | 3 | PS50947 | |
| Domain | dDENN | 1.25e-03 | 16 | 256 | 3 | SM00801 | |
| Domain | DENN | 1.25e-03 | 16 | 256 | 3 | SM00799 | |
| Domain | DENN | 1.25e-03 | 16 | 256 | 3 | PF02141 | |
| Domain | dDENN | 1.25e-03 | 16 | 256 | 3 | PF03455 | |
| Domain | - | 1.25e-03 | 16 | 256 | 3 | 1.20.1110.10 | |
| Domain | dDENN_dom | 1.25e-03 | 16 | 256 | 3 | IPR005112 | |
| Domain | uDENN_dom | 1.25e-03 | 16 | 256 | 3 | IPR005113 | |
| Domain | DENN | 1.25e-03 | 16 | 256 | 3 | PS50211 | |
| Domain | DENN_dom | 1.25e-03 | 16 | 256 | 3 | IPR001194 | |
| Domain | Cation_ATPase_C | 1.50e-03 | 17 | 256 | 3 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.50e-03 | 17 | 256 | 3 | IPR006068 | |
| Domain | HEAT_type_2 | 1.50e-03 | 17 | 256 | 3 | IPR021133 | |
| Domain | - | 1.78e-03 | 18 | 256 | 3 | 3.30.470.20 | |
| Domain | CPSASE_1 | 1.82e-03 | 5 | 256 | 2 | PS00866 | |
| Domain | - | 1.97e-03 | 95 | 256 | 6 | 2.60.120.200 | |
| Domain | Laminin_G_2 | 2.14e-03 | 40 | 256 | 4 | PF02210 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.67e-05 | 59 | 196 | 7 | M27218 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJB11 HBS1L ACACA CCT3 USP11 ACLY DLGAP5 FBXO22 FDPS PI4KA DDX54 AHCY DDX23 DDX43 GCN1 SDC4 RANBP2 CAD ESYT1 ISOC1 MYO1B CHD7 XPC UPF1 IPO9 OXCT1 LLGL1 GTF3C1 NANS FANCI SLC25A13 LTN1 MACF1 EIF3B DCTN4 DDX21 MAP2K3 AGRN SNRNP200 ATP5F1A | 1.76e-13 | 1353 | 263 | 40 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DNAJB11 CNNM2 KIF1A USP11 ACLY AASDHPPT PRUNE1 FBXO22 NUP210 DDX54 MTMR3 HAX1 DMD GCN1 VCPIP1 CARM1 RANBP2 IPO8 PITRM1 ESYT1 RTN4 LAMB2 APRT NCKAP5L KANK2 ARAF SEPSECS GTF3C1 FANCI SEC11A LTN1 ATP2A1 SNRNP200 | 7.52e-13 | 974 | 263 | 33 | 28675297 |
| Pubmed | BRIX1 EPPK1 ACACA CCT3 KIF1A USP11 ACLY INTS1 DDX42 TASOR2 SYNE2 NUP210 PWP2 DDX54 DDX23 GCN1 RANBP2 CAD MYO1B CHD7 UPF1 GTF3C1 FANCI SLC25A13 MACF1 DDX21 SNRNP200 | 1.15e-12 | 653 | 263 | 27 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | BRIX1 DNAJB11 EPPK1 CCT3 ACLY INTS1 DDX42 ABCB1 NCBP3 PI4KA SYNE2 NUP210 PWP2 DDX54 AHCY DDX23 GCN1 RANBP2 CAD SYNE1 LAMB2 MYO1B APRT GTF3C1 SLC25A13 TBK1 XPNPEP3 MACF1 EIF3B DDX21 SNRNP200 NEURL4 ATP5F1A | 2.90e-12 | 1024 | 263 | 33 | 24711643 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 TBC1D9B EPPK1 ACACA INTS1 OBSCN DGKQ PTCH1 NPHP4 ITGB4 KMT2C FAT1 PI4KA MTMR3 NAV1 DENND5A MCF2L GCN1 ALOX5 IGSF3 NPC1 SZT2 ESYT1 HECTD4 TRMT1 LAMA5 LAMB2 HDAC7 C2CD3 FANCI ZNF500 ATP2A3 AGRN MYBL2 | 4.68e-12 | 1105 | 263 | 34 | 35748872 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TBC1D9B EPPK1 AIMP1 ACLY CFTR DBN1 ITGB4 NUP210 AHCY HAX1 RANBP2 CAD IPO8 ESYT1 LAMA5 MYO1B UPF1 AKAP12 IPO9 SLC25A13 XPNPEP3 LTN1 ATP2A1 ATP2A3 ATP5F1A MX2 | 5.81e-12 | 647 | 263 | 26 | 26618866 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 ACACA CCT3 AIMP1 FDPS FDXR AHCY HAX1 GCN1 VCPIP1 CARM1 RANBP2 CAD COPZ1 EXOSC1 TRMT1 UPF1 OXCT1 GTF3C1 SLC25A13 SEC11A LTN1 SMARCD2 DCTN4 ATP2A3 SNRNP200 ATP5F1A | 6.48e-12 | 704 | 263 | 27 | 29955894 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CALCOCO2 BRIX1 HBS1L ACACA CCT3 KIF1A AIMP1 ACLY DDX42 DBN1 PI4KA NUP210 PWP2 DDX54 AHCY HAX1 GCN1 RANBP2 CAD IPO8 PITRM1 ESYT1 SYNE1 RTN4 MYO1B UPF1 CWC22 IPO9 RNF2 GTF3C1 FANCI SLC25A13 TBK1 SEC11A EIF3B DDX21 SNRNP200 ATP5F1A | 1.63e-11 | 1425 | 263 | 38 | 30948266 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | TBC1D9B USP11 ABCB1 PI4KA DMD GCN1 CNTN1 CAD LAMA5 LAMB2 MYO1B IPO9 LLGL1 GTF3C1 FANCI LTN1 SNRNP200 NEURL4 | 3.95e-11 | 313 | 263 | 18 | 38270169 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CNNM2 SARM1 NUP210 PWP2 MTMR3 GCN1 YIPF6 IPO8 PITRM1 RTN4 FASTKD1 EXOSC1 TRMT1 UPF1 KANK2 SEPSECS FANCI JRK TBK1 RBPMS2 XPNPEP3 LTN1 INTS4 EIF3B DDX21 NEURL4 | 1.64e-10 | 754 | 263 | 26 | 33060197 |
| Pubmed | GABRB3 DNAJB11 ACACA AIMP1 CNST ANKS1B AASDHPPT PALMD DBN1 NDUFS6 PRUNE1 MAGI2 FDPS PI4KA NAV1 HAX1 GCN1 ALDH6A1 IGSF3 VCPIP1 RANBP2 AMPH CAD SLC4A7 SLC4A8 ANK2 HCN4 RTN4 ISOC1 OXCT1 MACF1 EIF3B | 2.09e-10 | 1139 | 263 | 32 | 36417873 | |
| Pubmed | HBS1L CCT3 ACLY PRUNE1 AHCY GCN1 VCPIP1 CARM1 RANBP2 CAD ANK2 ESYT1 RTN4 ISOC1 MYO1B UPF1 DENND4C AKAP12 LLGL1 FANCI SLC25A13 SEC11A MACF1 SNRNP200 ATP5F1A | 2.30e-10 | 708 | 263 | 25 | 39231216 | |
| Pubmed | CCT3 DLGAP5 ANKS1B DBN1 EPM2AIP1 MAGI2 PI4KA SYNE2 NAV1 CNTN1 CARM1 RANBP2 CAD SLC4A8 ANK2 HCN4 SYNE1 HCN3 HECTD4 CHD7 UPF1 KANK2 AKAP12 SPTBN4 TBK1 MACF1 RAPGEF2 AGRN NEURL4 | 3.24e-10 | 963 | 263 | 29 | 28671696 | |
| Pubmed | CCT3 DDX42 ANKS1B DBN1 TASOR2 ABCB1 MIA2 TCHHL1 SYNE2 PWP2 PKHD1 DDX23 DMD MCF2L RANBP2 ANK2 PCDHGA3 SYNE1 MYO1B XPC PRX PPP4R4 SPTBN4 C2CD3 MTAP RNF2 GTF3C1 SLC25A13 MACF1 SMARCD2 DDX21 ATP2A1 ATP2A3 PCDHGC3 ATP5F1A DOP1A | 3.57e-10 | 1442 | 263 | 36 | 35575683 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | ACACA CCT3 ACLY PWP2 DDX54 GCN1 RANBP2 CAD MYO1B IPO9 SLC25A13 EIF3B DDX21 SNRNP200 ATP5F1A | 3.07e-09 | 272 | 263 | 15 | 25315684 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | DNAJB11 CNNM2 CCT3 USP11 ACLY DLGAP5 INTS1 DBN1 HAX1 GCN1 CAD IPO8 SYNE1 RTN4 MYO1B FANCI SLC25A13 INTS4 EIF3B SNRNP200 TUBAL3 | 3.51e-09 | 573 | 263 | 21 | 28330616 |
| Pubmed | DNAJB11 INTS1 ITGB4 KMT2C PI4KA FDXR SYNE2 ANKRD12 DMD SLC4A7 MYO1B IPO9 RNF2 FANCI MACF1 CDH13 | 4.04e-09 | 322 | 263 | 16 | 26514267 | |
| Pubmed | STK36 EPPK1 ACACA GLYCTK AASDHPPT FDPS PI4KA SYNE2 NUP210 DDX23 DMD CASP8AP2 RBPMS CAD IPO8 SYNE1 LAMA5 UPF1 KANK2 ARAF ADGB SLC25A13 JRK SNRNP200 | 4.10e-09 | 754 | 263 | 24 | 35906200 | |
| Pubmed | CALCOCO2 BRIX1 DNAJB11 HBS1L GLT8D1 EPPK1 ACACA CCT3 ACLY DLGAP5 FAT1 FBXO22 SYNE2 NUP210 AHCY SDC4 NPC1 CAD COL12A1 ESYT1 RTN4 LAMA5 MYO1B APRT PAPSS1 KANK2 AKAP12 TBK1 SEC11A LAMTOR3 MACF1 ATP5F1A | 4.95e-09 | 1297 | 263 | 32 | 33545068 | |
| Pubmed | BRIX1 ACACA CCT3 ACLY ABCB1 AHCY NPC1 CARM1 RANBP2 CAD SLC4A7 PITRM1 ESYT1 UPF1 SLC25A13 SEC11A LAMTOR3 EIF3B ATP5F1A | 6.68e-09 | 484 | 263 | 19 | 31995728 | |
| Pubmed | STK36 HBS1L TBC1D9B SARM1 NPHP4 SLITRK1 NUP210 SLC4A8 CLSTN1 ATP10A PRX PPP4R4 VPS13D IPO9 LTN1 MACF1 SNRNP200 NEURL4 DOP1A | 8.98e-09 | 493 | 263 | 19 | 15368895 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | ACACA CCT3 USP11 ACLY FBXO22 AHCY GCN1 RANBP2 CAD MYO1B SLC25A13 DDX21 ATP2A1 SNRNP200 ATP5F1A TUBAL3 | 1.03e-08 | 344 | 263 | 16 | 36282215 |
| Pubmed | DNAJB11 ACACA CCT3 AASDHPPT DBN1 FBXO22 NUP210 AHCY GCN1 IGSF3 NPC1 CAD LAMA5 LAMB2 ARAF SLC25A13 SEC11A EIF3B DDX21 SNRNP200 ATP5F1A | 1.14e-08 | 613 | 263 | 21 | 22268729 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BRIX1 CCT3 USP11 SARM1 NDUFS6 MIA2 NDUFAF7 PI4KA SYNE2 PWP2 DDX54 MTMR3 NAV1 HAX1 VCPIP1 CAD SLC4A7 IPO8 PITRM1 ESYT1 SYNE1 RTN4 FASTKD1 TRMT1 ARMC10 R3HDM2 UPF1 ARAF VPS13D OXCT1 SLC25A13 DDX21 NEURL4 ATP5F1A | 1.21e-08 | 1496 | 263 | 34 | 32877691 |
| Pubmed | KIF1A COG3 TMEM161A PIK3R2 PI4KA SYNE2 DDX54 NPC1 SLC4A7 ESYT1 RTN4 SCYL3 SLC1A1 DENND4C AKAP12 VPS13D LRIG1 LAMTOR3 DCTN4 | 1.28e-08 | 504 | 263 | 19 | 34432599 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CALCOCO2 PRAMEF7 EPPK1 CCT3 OBSCN DBN1 NPHP4 NDUFS6 PI4KA GCN1 RBPMS CAD ESYT1 PRAMEF8 VPS13D IPO9 OXCT1 LTN1 NEURL4 ATP5F1A | 1.45e-08 | 564 | 263 | 20 | 21565611 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | EPPK1 CCT3 DBN1 FREM2 GCN1 CAD LAMA5 LAMB2 XPC GTF3C1 AGRN SNRNP200 ATP5F1A | 1.47e-08 | 219 | 263 | 13 | 31353912 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DNAJB11 EPPK1 ACACA CCT3 AIMP1 USP11 ACLY DDX42 DBN1 ME1 AHCY GCN1 RANBP2 CAD COPZ1 MYO1B UPF1 APRT AKAP12 IPO9 MTAP GTF3C1 FANCI XPNPEP3 MACF1 EIF3B DCTN4 SNRNP200 ATP5F1A | 1.68e-08 | 1149 | 263 | 29 | 35446349 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DNAJB11 INTS1 DDX42 DBN1 DDX23 HAX1 GCN1 ARHGEF6 RANBP2 CAD SYNE1 HECTD4 MYO1B CHD7 XPC UPF1 CWC22 LLGL1 GTF3C1 SLC25A13 SEC11A XPNPEP3 INTS4 MACF1 EIF3B DDX21 AGRN SNRNP200 | 1.79e-08 | 1082 | 263 | 28 | 38697112 |
| Pubmed | BRIX1 ACACA CCT3 AIMP1 ACLY NUP210 PWP2 GCN1 CARM1 RANBP2 CAD IPO8 COPZ1 ESYT1 UPF1 IPO9 FANCI SLC25A13 EIF3B DDX21 SNRNP200 | 2.25e-08 | 638 | 263 | 21 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | BRIX1 HBS1L ACACA CCT3 AIMP1 ACLY INTS1 AASDHPPT PWP2 DDX54 DDX23 DDX43 GCN1 CARM1 RANBP2 CAD ESYT1 CHD7 UPF1 APRT CWC22 IPO9 SLC25A13 SMARCD2 EIF3B DDX21 MAP2K3 AGRN SNRNP200 ATP5F1A TUBAL3 | 2.61e-08 | 1318 | 263 | 31 | 30463901 |
| Pubmed | BRIX1 DNAJB11 USP11 DDX42 NDUFS6 NCBP3 PIK3R2 PI4KA SYNE2 NUP210 PWP2 DDX54 DDX23 HAX1 CASP8AP2 CAD SLC4A7 IPO8 ANK2 ESYT1 SYNE1 RTN4 UPF1 NCKAP5L KANK2 AKAP12 WDR19 LLGL1 KIRREL1 MACF1 DDX21 SNRNP200 NEURL4 | 3.55e-08 | 1487 | 263 | 33 | 33957083 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | BRIX1 HBS1L EPPK1 ACACA CCT3 AIMP1 ACLY FBXO22 MIA2 SYNE2 DDX54 AHCY NAV1 DDX23 HAX1 GCN1 VCPIP1 CARM1 RANBP2 CAD SLC4A7 TRMT1 ISOC1 UPF1 MTAP SLC25A13 XPNPEP3 MACF1 EIF3B DDX21 SNRNP200 ATP5F1A | 3.79e-08 | 1415 | 263 | 32 | 28515276 |
| Pubmed | ACACA ACLY PI4KA GCN1 RANBP2 CAD UPF1 ARAF FANCI SLC25A13 DDX21 SNRNP200 | 4.00e-08 | 197 | 263 | 12 | 31620119 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DNAJB11 GLT8D1 ACLY CNTNAP3 ITGB4 OLFML2A TMEM161A FAT1 FBXO22 MIA2 NUP210 IGSF3 NPC1 COL12A1 ESYT1 RTN4 LAMA5 ISOC1 LAMB2 CLSTN1 ARSA GTF3C1 FANCI SEC11A LTN1 KIRREL1 ATP2A3 AGRN CDH13 | 4.37e-08 | 1201 | 263 | 29 | 35696571 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 ACACA OBSCN ME1 SLITRK1 NCBP3 KMT2C FBXO22 APEX2 KIF19 DDX54 DDX23 RTN4 ARAF VPS13D GTF3C1 SLC25A13 ATP2A3 | 5.70e-08 | 497 | 263 | 18 | 36774506 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 ACACA CCT3 ACLY COG3 ME1 AHCY GCN1 CAD ESYT1 SYNE1 RTN4 ISOC1 MYO1B UPF1 APRT MTAP NANS MACF1 EIF3B ATP2A1 SNRNP200 ATP5F1A | 6.55e-08 | 807 | 263 | 23 | 30575818 |
| Pubmed | PRAMEF7 HBS1L CNST DLGAP5 DDX42 OBSCN PPCDC PTCH1 ITGB4 KMT2C PI4KA ANKRD12 STK24 ARHGEF6 NPC1 SLC4A7 CHD7 PRAMEF8 AKAP12 TGM4 SEPSECS FEZ2 LTN1 MACF1 DDX21 AGRN ATP5F1A | 7.08e-08 | 1084 | 263 | 27 | 11544199 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DNAJB11 HBS1L ACACA CCT3 AIMP1 USP11 ACLY AASDHPPT COG3 ME1 FDPS AHCY GCN1 STK24 VCPIP1 CARM1 COPZ1 TRMT1 ISOC1 LAMB2 GINS4 PAPSS1 AKAP12 IPO9 OXCT1 MTAP NANS FANCI MACF1 EIF3B DCTN4 SNRNP200 | 7.16e-08 | 1455 | 263 | 32 | 22863883 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | DNAJB11 HBS1L CCT3 AASDHPPT PI4KA HAX1 GCN1 VCPIP1 CARM1 RANBP2 CAD ESYT1 RTN4 RNF2 GTF3C1 FANCI SLC25A13 EIF3B ATP5F1A | 9.10e-08 | 571 | 263 | 19 | 37167062 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPPK1 ACLY DLGAP5 DDX42 GCN1 VCPIP1 RANBP2 SLC4A7 ESYT1 RTN4 KANK2 DENND4C SNRNP200 | 9.22e-08 | 256 | 263 | 13 | 33397691 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB11 ACACA CCT3 AIMP1 USP11 ACLY INTS1 AASDHPPT NUP210 AHCY DDX23 HAX1 GCN1 CARM1 RANBP2 CAD ESYT1 TRMT1 MYO1B UPF1 GTF3C1 FANCI SLC25A13 SEC11A EIF3B DCTN4 DDX21 SNRNP200 ATP5F1A | 1.14e-07 | 1257 | 263 | 29 | 37317656 |
| Pubmed | CCT3 AIMP1 ACLY DBN1 DDX54 AHCY GCN1 CARM1 RANBP2 CAD IPO8 TRMT1 UPF1 APRT RNF2 SEC11A EIF3B DDX21 SNRNP200 ATP5F1A | 1.17e-07 | 641 | 263 | 20 | 36057605 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | BRIX1 EPPK1 AIMP1 SARM1 DBN1 PTCH1 MAGI2 SYNE2 CNTN1 CARM1 CAD RTN4 CHD7 UPF1 MACF1 | 1.17e-07 | 358 | 263 | 15 | 32460013 |
| Pubmed | BRIX1 HBS1L CCT3 AIMP1 USP11 ACLY AASDHPPT FBXO22 HMCN2 AHCY MTMR3 HAX1 CARM1 RANBP2 CAD IPO8 ISOC1 GINS4 UPF1 IPO9 MTAP RNF2 GTF3C1 SLC25A13 SMARCD2 EIF3B DDX21 SNRNP200 ATP5F1A TUBAL3 | 1.20e-07 | 1335 | 263 | 30 | 29229926 | |
| Pubmed | DNAJB11 CCT3 ME1 PI4KA SYNE2 NUP210 DDX54 MTMR3 HAX1 DMD GCN1 RANBP2 CAD SCYL3 MYO1B NCKAP5L PPP4R4 POSTN C2CD3 IPO9 FANCI LTN1 INTS4 KIRREL1 NEURL4 ATP5F1A | 1.38e-07 | 1049 | 263 | 26 | 27880917 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CALCOCO2 INTS1 EPM2AIP1 NFATC4 PIK3R2 FDXR AHCY DDX43 HAX1 STK24 CARM1 MYO1B KANK2 ARAF PRX LIMK2 RNF2 GTF3C1 TBK1 LAMTOR3 EIF3B DCTN4 MAP2K3 TUBAL3 | 1.40e-07 | 910 | 263 | 24 | 36736316 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | BRIX1 DNAJB11 CCT3 ACLY DDX42 DBN1 NCBP3 AHCY DDX23 GCN1 ALDH6A1 CAD IPO8 SYNE1 UPF1 CWC22 EIF3B DDX21 SNRNP200 ATP5F1A TUBAL3 | 1.49e-07 | 714 | 263 | 21 | 28302793 |
| Pubmed | DNAJB11 ACACA AIMP1 FBXO22 AHCY HAX1 GCN1 ALDH6A1 RANBP2 CAD UPF1 PAPSS1 IPO9 OXCT1 GTF3C1 FANCI XPNPEP3 DDX21 | 1.66e-07 | 534 | 263 | 18 | 35032548 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | BRIX1 STK36 DNAJB11 EPPK1 ACACA USP11 ACLY MAGI2 KMT2C AHCY DDX23 GCN1 STK24 RANBP2 SLC4A7 RTN4 MYO1B APRT HDAC7 ARAF KPTN IPO9 FANCI SEC11A HAS1 DDX21 ATP2A3 SNRNP200 NEURL4 | 1.78e-07 | 1284 | 263 | 29 | 17353931 |
| Pubmed | INTS1 DBN1 PWP2 GCN1 RANBP2 CAD MYO1B RNF2 GTF3C1 EIF3B DDX21 SNRNP200 ZNF654 | 1.86e-07 | 272 | 263 | 13 | 31010829 | |
| Pubmed | DNAJB11 TBC1D9B CCT3 AIMP1 COG3 NCBP3 FDPS SYNE2 NUP210 DDX54 DDX23 HAX1 GCN1 RANBP2 CAD IPO8 ESYT1 RTN4 EXOSC1 MYO1B UPF1 APRT IPO9 OXCT1 GTF3C1 FANCI SLC25A13 LTN1 EIF3B SNRNP200 ATP5F1A | 1.86e-07 | 1440 | 263 | 31 | 30833792 | |
| Pubmed | CCT3 AIMP1 GCN1 CARM1 CAD COPZ1 MYO1B UPF1 PAPSS1 KANK2 IPO9 RNF2 GTF3C1 SLC25A13 TBK1 MACF1 DDX21 SNRNP200 ATP5F1A | 2.00e-07 | 601 | 263 | 19 | 33658012 | |
| Pubmed | CCT3 ITGB4 KMT2C PIK3R2 NAV1 DMD GCN1 CASP8AP2 RANBP2 SYNE1 LAMB2 NCKAP5L ARAF RASAL3 MACF1 RAPGEF2 SNRNP200 | 2.19e-07 | 486 | 263 | 17 | 20936779 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 2.21e-07 | 56 | 263 | 7 | 9455484 | |
| Pubmed | CALCOCO2 DNAJB11 HBS1L GLT8D1 AIMP1 CNST ACLY KATNB1 INTS1 DDX42 MIA2 PI4KA NUP210 DDX54 GCN1 NPC1 RANBP2 CAD CRACR2A ESYT1 IPO9 RASAL3 GTF3C1 FANCI DDX21 MAP2K3 ATP5F1A | 3.10e-07 | 1168 | 263 | 27 | 19946888 | |
| Pubmed | CALCOCO2 ACACA CCT3 ACLY ME1 PIK3R2 FDPS DDX54 AHCY GCN1 RANBP2 CAD COPZ1 RTN4 MYO1B UPF1 APRT PAPSS1 HDAC7 ARAF IPO9 RNF2 SLC25A13 TBK1 EIF3B DDX21 MAP2K3 ATP5F1A | 3.31e-07 | 1247 | 263 | 28 | 27684187 | |
| Pubmed | TBC1D9B KIF1A USP11 AASDHPPT NDUFS6 MIA2 FDXR PWP2 AHCY STK24 NPC1 RANBP2 CAD PITRM1 APRT DENND4C ARSA LLGL1 DDX21 MAP2K3 | 3.42e-07 | 686 | 263 | 20 | 28380382 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | DNAJB11 ACLY SYNE2 DMD CARM1 PITRM1 SYNE1 CHD7 LLGL1 RNF2 MACF1 | 3.55e-07 | 197 | 263 | 11 | 20811636 |
| Pubmed | 4.09e-07 | 159 | 263 | 10 | 31332168 | ||
| Pubmed | 4.34e-07 | 160 | 263 | 10 | 31678930 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ACACA CCT3 ITGB4 PI4KA NUP210 GCN1 CAD MYO1B LTN1 SNRNP200 NEURL4 | 4.56e-07 | 202 | 263 | 11 | 33005030 |
| Pubmed | EPPK1 ACACA CCT3 AIMP1 ACLY MIA2 AHCY GCN1 RANBP2 CAD SLC4A7 ESYT1 MYO1B CWC22 GTF3C1 | 4.66e-07 | 399 | 263 | 15 | 37536630 | |
| Pubmed | EPPK1 CCT3 AASDHPPT DBN1 NUP210 AHCY GCN1 RANBP2 CAD IPO8 ESYT1 SYNE1 SLC25A13 DDX21 SNRNP200 ATP5F1A | 5.88e-07 | 463 | 263 | 16 | 34901782 | |
| Pubmed | 6.43e-07 | 167 | 263 | 10 | 22159717 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | BRIX1 NCBP3 RMI1 PI4KA DDX54 HAX1 CHD7 XPC CWC22 RNF2 GTF3C1 JRK SMARCD2 EIF3B SNRNP200 | 6.55e-07 | 410 | 263 | 15 | 26949251 |
| Pubmed | 7.00e-07 | 130 | 263 | 9 | 12421765 | ||
| Pubmed | OBSCN DBN1 NUP210 PWP2 LOXL4 ALOX5 NPC1 SYNE1 LAMA5 IPO9 FANCI | 8.08e-07 | 214 | 263 | 11 | 22199357 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 ACACA NCBP3 MAGI2 CNTN1 COL6A3 COL12A1 TNC HECTD4 LAMA5 CHD7 PRAMEF8 LRIG1 FANCI | 8.35e-07 | 363 | 263 | 14 | 14691545 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPPK1 ACACA CCT3 ACLY DBN1 NUP210 AHCY GCN1 RANBP2 CAD MYO1B ARAF EIF3B DDX21 SNRNP200 ATP5F1A | 8.69e-07 | 477 | 263 | 16 | 31300519 |
| Pubmed | DNAJB11 ACACA USP11 PI4KA NUP210 DDX54 DDX23 STK24 RANBP2 IPO8 COPZ1 SZT2 MYO1B ARAF VPS13D FANCI TBK1 MAP2K3 | 1.03e-06 | 606 | 263 | 18 | 36538041 | |
| Pubmed | ACACA DLGAP5 PRUNE1 FDPS AHCY CARM1 RANBP2 SLC4A7 ANK2 AKAP12 DCTN4 DDX21 | 1.06e-06 | 267 | 263 | 12 | 33417871 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.21e-06 | 179 | 263 | 10 | 36261009 | |
| Pubmed | CCT3 USP11 ACLY DDX42 DBN1 TASOR2 AHCY DDX23 CARM1 CAD IPO8 UPF1 XPNPEP3 EIF3B DDX21 SNRNP200 ATP5F1A | 1.24e-06 | 551 | 263 | 17 | 34728620 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | BRIX1 EPPK1 CCT3 AIMP1 ACLY DBN1 ITGB4 TASOR2 NUP210 PWP2 DDX54 AHCY NAV1 SDC4 CAD ESYT1 ISOC1 MYO1B UPF1 CWC22 GTF3C1 SLC25A13 SMARCD2 EIF3B DDX21 SNRNP200 ATP5F1A | 1.27e-06 | 1257 | 263 | 27 | 36526897 |
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | DNAJB11 TBC1D9B EPPK1 CCT3 ACLY OBSCN SYNE2 AHCY CARM1 CAD ESYT1 IPO9 EIF3B | 1.29e-06 | 323 | 263 | 13 | 25959826 |
| Pubmed | HBS1L USP11 ACLY PWP2 DDX23 HAX1 ESYT1 RTN4 MYO1B CWC22 IPO9 FANCI SLC25A13 LTN1 INTS4 SNRNP200 ATP5F1A | 1.54e-06 | 560 | 263 | 17 | 35241646 | |
| Pubmed | BRIX1 CCT3 ACLY RMI1 GCN1 CAD IPO8 UPF1 IPO9 SLC25A13 INTS4 DDX21 NEURL4 ATP5F1A | 1.57e-06 | 383 | 263 | 14 | 29331416 | |
| Pubmed | 1.65e-06 | 144 | 263 | 9 | 35681168 | ||
| Pubmed | 1.70e-06 | 4 | 263 | 3 | 12403779 | ||
| Pubmed | 1.70e-06 | 4 | 263 | 3 | 34504132 | ||
| Pubmed | 1.70e-06 | 4 | 263 | 3 | 21186323 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | BRIX1 DNAJB11 ZBTB48 DBN1 ENOPH1 NDUFS6 RMI1 KMT2C PI4KA SYNE2 DENND5A MCF2L ARHGEF6 CNTN1 AMPH RTN4 UPF1 AKAP12 SPTBN4 GTF3C1 WFIKKN1 LAMTOR3 MAP2K3 CDH13 MYBL2 | 1.74e-06 | 1124 | 263 | 25 | 21900206 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | BRIX1 HBS1L USP11 NCBP3 SERPINB10 DDX54 NAV1 DDX23 HAX1 RANBP2 STON1 EXOSC1 ARAF KPTN DCLK3 DDX21 MAP2K3 SNRNP200 NEURL4 | 1.75e-06 | 695 | 263 | 19 | 23602568 |
| Pubmed | 1.85e-06 | 146 | 263 | 9 | 27068509 | ||
| Pubmed | BRIX1 DNAJB11 EPPK1 AIMP1 PIK3R2 PI4KA DDX54 AHCY LOXL4 MYO1B XPC ARAF FANCI SLC25A13 MACF1 SMARCD2 DCTN4 DDX21 | 1.95e-06 | 634 | 263 | 18 | 34591612 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DNAJB11 ACACA CCT3 ACLY INTS1 DDX42 NDUFS6 MAGI2 FAT1 TCHHL1 FDXR LOXL4 VCPIP1 CARM1 SLC4A7 COPZ1 PITRM1 ESYT1 FASTKD1 LAMA5 LAMB2 CLSTN1 MTAP LRIG1 SEC11A XPNPEP3 AGRN SNRNP200 ATP5F1A | 2.10e-06 | 1451 | 263 | 29 | 30550785 |
| Pubmed | OBSCN ENOPH1 NDUFS6 TASOR2 FREM2 FAT1 FDPS YIPF6 COL6A3 RBPMS ANK2 RTN4 LAMB2 MYO1B NCKAP5L KANK2 DENND4C SEPSECS ARSA FANCI WFIKKN1 LTN1 ZNF500 RAPGEF2 AGRN CDH13 | 2.16e-06 | 1215 | 263 | 26 | 15146197 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BRIX1 ACACA CCT3 ACLY DLGAP5 DDX42 FBXO22 FDXR PWP2 DDX54 DDX23 RANBP2 ESYT1 TRMT1 MYO1B CWC22 RNF2 GTF3C1 FANCI SLC25A13 DDX21 SNRNP200 ATP5F1A | 2.20e-06 | 989 | 263 | 23 | 36424410 |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | HBS1L CCT3 PWP2 DDX54 DDX23 NPC1 CAD EXOSC1 VPS13D SLC25A13 TBK1 DDX21 MAP2K3 SNRNP200 ATP5F1A | 2.31e-06 | 454 | 263 | 15 | 33226137 |
| Pubmed | AASDHPPT DBN1 NDUFS6 MAGI2 FDPS AHCY ANK2 TNC LAMB2 CLSTN1 MTAP MACF1 ATP5F1A | 2.35e-06 | 341 | 263 | 13 | 29791485 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 CCT3 INTS1 DDX42 DDX23 GCN1 STK24 RANBP2 CHD7 UPF1 IPO9 RNF2 FANCI MACF1 DDX21 MAP2K3 SNRNP200 | 2.58e-06 | 582 | 263 | 17 | 20467437 |
| Pubmed | DNAJB11 CCT3 ITGB4 FAT1 HAX1 GCN1 CAD MYO1B ARAF LIMK2 LLGL1 SLC25A13 DDX21 ATP5F1A | 2.67e-06 | 401 | 263 | 14 | 25852190 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CCT3 DDX42 TASOR2 RMI1 NDUFAF7 AHCY DDX23 GCN1 RANBP2 IPO8 COPZ1 SYNE1 XPC PAPSS1 CWC22 KANK2 AKAP12 GTF3C1 SMARCD2 EIF3B DCTN4 DDX21 SNRNP200 NEURL4 MYBL2 | 2.80e-06 | 1155 | 263 | 25 | 20360068 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACA CCT3 ACLY DLGAP5 DDX42 AASDHPPT DBN1 PRUNE1 AHCY GCN1 VCPIP1 RANBP2 ANK2 ESYT1 RTN4 MYO1B UPF1 AKAP12 MACF1 DDX21 SNRNP200 ATP5F1A | 3.01e-06 | 934 | 263 | 22 | 33916271 |
| Pubmed | ACLY TMEM161A NUP210 HAX1 GCN1 RANBP2 IPO8 RTN4 AKAP12 IPO9 RNF2 FANCI SEC11A LTN1 EIF3B DDX21 SNRNP200 ATP5F1A | 3.19e-06 | 657 | 263 | 18 | 36180527 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | AIMP1 NPHP4 TMEM161A NAV1 GCN1 ARHGEF6 IPO8 COPZ1 PITRM1 ESYT1 NCKAP5L SLC1A1 HDAC7 ARAF DENND4C AKAP12 WDR19 POSTN SEPSECS IPO9 RNF2 NANS TBK1 XPNPEP3 DCTN4 SNRNP200 NEURL4 | 3.20e-06 | 1321 | 263 | 27 | 27173435 |
| Pubmed | AIMP1 PI4KA NUP210 HAX1 GCN1 RANBP2 IPO8 AKAP12 FANCI LTN1 EIF3B DDX21 SNRNP200 ATP5F1A | 3.26e-06 | 408 | 263 | 14 | 33766124 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B GLT8D1 KIF1A AIMP1 ACLY SARM1 PI4KA NUP210 GCN1 VCPIP1 NPC1 RANBP2 ESYT1 RTN4 UPF1 CLSTN1 IPO9 LRIG1 FANCI TBK1 SEC11A KIRREL1 | 3.45e-06 | 942 | 263 | 22 | 31073040 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 3.60e-06 | 84 | 263 | 7 | 25670202 | |
| Interaction | TOP3B interactions | CALCOCO2 STK36 TBC1D9B EPPK1 ACACA AIMP1 INTS1 OBSCN DGKQ PTCH1 NPHP4 ITGB4 RMI1 KMT2C FAT1 FBXO22 PI4KA MTMR3 NAV1 DENND5A MCF2L GCN1 ALOX5 IGSF3 NPC1 CAD SZT2 ESYT1 HECTD4 TRMT1 LAMA5 LAMB2 MYO1B R3HDM2 UPF1 APRT KANK2 HDAC7 C2CD3 FANCI SLC25A13 ZNF500 DCTN4 ATP2A3 AGRN MYBL2 | 1.73e-08 | 1470 | 260 | 46 | int:TOP3B |
| Interaction | KCNA3 interactions | HBS1L EPPK1 CCT3 ACLY PRUNE1 KMT2C AHCY PKHD1 GCN1 VCPIP1 CARM1 RANBP2 CAD ANK2 SZT2 ESYT1 RTN4 ISOC1 MYO1B UPF1 SLC1A1 DENND4C AKAP12 LLGL1 FANCI SLC25A13 SEC11A MACF1 SNRNP200 ATP5F1A DOP1A OTOG | 1.02e-07 | 871 | 260 | 32 | int:KCNA3 |
| Interaction | GML interactions | 7.57e-07 | 58 | 260 | 8 | int:GML | |
| Interaction | SIRT7 interactions | BRIX1 EPPK1 ACACA CCT3 KIF1A USP11 ACLY INTS1 DDX42 TASOR2 SYNE2 NUP210 PWP2 DDX54 DDX23 GCN1 RANBP2 CAD MYO1B CHD7 UPF1 GTF3C1 FANCI SLC25A13 MACF1 DDX21 SNRNP200 | 1.39e-06 | 744 | 260 | 27 | int:SIRT7 |
| Interaction | EED interactions | BRIX1 DNAJB11 TBC1D9B ACACA CCT3 ACLY INTS1 DDX42 OBSCN DBN1 TASOR2 PRUNE1 NUP210 PWP2 DDX54 CARM1 RANBP2 COPZ1 SZT2 HCN3 LAMA5 MYO1B CHD7 UPF1 APRT CWC22 IPO9 RNF2 GTF3C1 SLC25A13 TBK1 SEC11A LTN1 MACF1 EIF3B DDX21 MAP2K3 AGRN SNRNP200 ATP5F1A MYBL2 | 1.52e-06 | 1445 | 260 | 41 | int:EED |
| Interaction | LGALS9 interactions | BRIX1 ACACA CCT3 USP11 ACLY CFTR ABCB1 AHCY IGSF3 NPC1 CARM1 RANBP2 CAD SLC4A7 PITRM1 ESYT1 UPF1 SLC1A1 SLC25A13 SEC11A LAMTOR3 EIF3B ATP5F1A | 2.54e-06 | 588 | 260 | 23 | int:LGALS9 |
| Interaction | OPALIN interactions | INTS1 TMEM161A PI4KA GCN1 SLC4A7 IPO8 CRACR2A FASTKD1 SLC1A1 ARAF FANCI LTN1 ATP2A1 | 3.44e-06 | 209 | 260 | 13 | int:OPALIN |
| Interaction | F2RL1 interactions | TBC1D9B INTS1 TMEM161A PI4KA GCN1 YIPF6 IPO8 RTN4 FASTKD1 FANCI ATP2A3 ATP5F1A | 4.52e-06 | 182 | 260 | 12 | int:F2RL1 |
| Interaction | ASXL1 interactions | DNAJB11 CCT3 USP11 ACLY KMT2C GCN1 CARM1 CAD ISOC1 IPO9 MTAP RNF2 SLC25A13 LTN1 ATP5F1A | 5.02e-06 | 286 | 260 | 15 | int:ASXL1 |
| Interaction | SLAMF1 interactions | INTS1 CNTNAP3 FAT1 LAMB2 CLSTN1 SLC1A1 FANCI LTN1 INTS4 ATP2A3 | 5.19e-06 | 125 | 260 | 10 | int:SLAMF1 |
| Interaction | RAB5A interactions | USP11 CFTR DBN1 COG3 TYRP1 SYNE2 DDX54 HAX1 CARM1 CAD SLC4A7 ESYT1 RTN4 SCYL3 DENND4C AKAP12 IPO9 LLGL1 FANCI KIRREL1 MACF1 EIF3B DCTN4 DDX21 NEURL4 | 5.34e-06 | 706 | 260 | 25 | int:RAB5A |
| Interaction | AXL interactions | DNAJB11 EPPK1 AIMP1 CFTR NPHS2 PIK3R2 DDX54 GCN1 ESYT1 RTN4 KANK2 SLC1A1 AKAP12 IPO9 LLGL1 FANCI SLC25A13 | 6.66e-06 | 369 | 260 | 17 | int:AXL |
| Interaction | CFTR interactions | DNAJB11 TBC1D9B EPPK1 ACACA CCT3 AIMP1 ACLY CFTR DBN1 ITGB4 SERPINB10 NUP210 PWP2 AHCY HAX1 DMD GCN1 RANBP2 CAD SLC4A7 SLC4A8 IPO8 TNC ESYT1 TRMT1 LAMA5 ISOC1 MYO1B UPF1 CWC22 AKAP12 IPO9 SLC25A13 XPNPEP3 LTN1 MACF1 ATP2A1 ATP2A3 ATP5F1A MX2 | 6.72e-06 | 1480 | 260 | 40 | int:CFTR |
| Interaction | RPS6KA2 interactions | KIF1A CDHR2 FAT1 PIK3R2 ALOX5 SLC4A7 IPO8 UPF1 IPO9 LTN1 KIRREL1 MACF1 | 9.63e-06 | 196 | 260 | 12 | int:RPS6KA2 |
| Interaction | MTNR1B interactions | 1.03e-05 | 135 | 260 | 10 | int:MTNR1B | |
| Interaction | ARRDC4 interactions | 1.18e-05 | 83 | 260 | 8 | int:ARRDC4 | |
| Interaction | FLOT1 interactions | USP11 CFTR DBN1 NDUFS6 PIK3R2 PI4KA HAX1 NPC1 CAD SLC4A7 ANK2 MYO1B NCKAP5L KANK2 AKAP12 LLGL1 KIRREL1 MACF1 ATP5F1A | 1.43e-05 | 475 | 260 | 19 | int:FLOT1 |
| Interaction | RUFY1 interactions | ACACA CCT3 USP11 ACLY FBXO22 AHCY GCN1 CARM1 RANBP2 CAD COPZ1 MYO1B SLC25A13 DDX21 ATP2A1 SNRNP200 KRT37 ATP5F1A TUBAL3 | 1.47e-05 | 476 | 260 | 19 | int:RUFY1 |
| Interaction | ILK interactions | DNAJB11 ACACA ZBTB48 CCT3 ITGB4 FAT1 HAX1 GCN1 CARM1 CAD POSTN FANCI SLC25A13 DDX21 ATP5F1A | 1.84e-05 | 319 | 260 | 15 | int:ILK |
| Interaction | FBXO6 interactions | CNTNAP3B DNAJB11 ACACA CCT3 AASDHPPT DBN1 NUP210 AHCY GCN1 IGSF3 NPC1 CAD COL12A1 TNC LAMA5 LAMB2 ARAF SLC25A13 SEC11A EIF3B DDX21 AGRN SNRNP200 ATP5F1A | 2.09e-05 | 717 | 260 | 24 | int:FBXO6 |
| Interaction | RIPK4 interactions | STK36 DNAJB11 CCT3 ACLY MAGI2 DDX54 HAX1 GCN1 SDC4 CAD ANK2 KANK2 ARAF AKAP12 WDR19 SLC25A13 MACF1 ATP5F1A | 2.14e-05 | 446 | 260 | 18 | int:RIPK4 |
| Interaction | ZNF746 interactions | ACACA CCT3 ACLY PWP2 DDX54 GCN1 RANBP2 CAD MYO1B IPO9 SLC25A13 EIF3B DDX21 SNRNP200 ATP5F1A | 2.37e-05 | 326 | 260 | 15 | int:ZNF746 |
| Interaction | PTEN interactions | STK36 ACACA CCT3 USP11 DBN1 MAGI2 FBXO22 PIK3R2 CACTIN-AS1 AHCY SDC4 NPC1 RANBP2 AMPH CAD PITRM1 EXOSC1 MYO1B XPC UPF1 APRT AKAP12 SLC25A13 DDX21 MAP2K3 AGRN SNRNP200 ATP5F1A | 2.83e-05 | 929 | 260 | 28 | int:PTEN |
| Interaction | PHLPP1 interactions | EPPK1 ACLY DLGAP5 DDX42 FBXO22 GCN1 VCPIP1 RANBP2 SLC4A7 ESYT1 RTN4 KANK2 DENND4C FANCI SNRNP200 | 3.03e-05 | 333 | 260 | 15 | int:PHLPP1 |
| Interaction | USP19 interactions | 3.24e-05 | 154 | 260 | 10 | int:USP19 | |
| Interaction | ODAPH interactions | 3.82e-05 | 49 | 260 | 6 | int:ODAPH | |
| Interaction | PRNP interactions | CALCOCO2 ZBTB48 INTS1 AASDHPPT DBN1 NDUFS6 EPM2AIP1 MAGI2 KMT2C FAT1 FDPS DENND4B AHCY HAX1 DMD CNTN1 COL12A1 IPO8 ANK2 TNC HCN3 FASTKD1 LAMB2 CLSTN1 AKAP12 IPO9 MTAP JRK ZNF500 MACF1 ATP5F1A OTOG | 4.05e-05 | 1158 | 260 | 32 | int:PRNP |
| Interaction | BCL2L14 interactions | 4.06e-05 | 127 | 260 | 9 | int:BCL2L14 | |
| Interaction | WDR76 interactions | EPPK1 CCT3 INTS1 DBN1 FREM2 GCN1 RANBP2 CAD LAMA5 LAMB2 CHD7 XPC GTF3C1 AGRN SNRNP200 ATP5F1A | 4.10e-05 | 383 | 260 | 16 | int:WDR76 |
| Interaction | ANKRD55 interactions | ACACA ACLY PI4KA GCN1 RANBP2 CAD UPF1 ARAF FANCI SLC25A13 DDX21 SNRNP200 | 4.32e-05 | 228 | 260 | 12 | int:ANKRD55 |
| Interaction | OBSL1 interactions | BRIX1 EPPK1 CCT3 AIMP1 ACLY DDX42 TASOR2 NCBP3 SYNE2 NUP210 PWP2 DDX54 DDX23 LOXL4 HAX1 GCN1 RANBP2 CAD SYNE1 LAMA5 KANK2 GTF3C1 XPNPEP3 MACF1 DDX21 SNRNP200 ATP5F1A | 4.46e-05 | 902 | 260 | 27 | int:OBSL1 |
| Interaction | MYCBP2 interactions | NMNAT2 TBC1D9B CCT3 USP11 DBN1 EPM2AIP1 SYNE2 CARM1 CAD ANK2 UPF1 AKAP12 RBPMS2 MACF1 NEURL4 | 6.28e-05 | 355 | 260 | 15 | int:MYCBP2 |
| Interaction | SIRT6 interactions | BRIX1 HBS1L ACACA USP11 ACLY TASOR2 FAT1 NUP210 PWP2 DDX54 RANBP2 CAD ESYT1 HECTD4 XPC UPF1 GTF3C1 SMARCD2 MAP2K3 PCDHGC3 SNRNP200 | 7.06e-05 | 628 | 260 | 21 | int:SIRT6 |
| Interaction | TRIM28 interactions | DNAJB11 EPPK1 ACACA CCT3 AIMP1 USP11 ACLY CFTR PTCH1 FDPS FDXR AHCY HAX1 GCN1 VCPIP1 CARM1 RANBP2 CAD IPO8 COPZ1 EXOSC1 TRMT1 UPF1 ZMIZ1 ARAF OXCT1 RNF2 GTF3C1 SLC25A13 SEC11A LTN1 SMARCD2 DCTN4 DDX21 ATP2A3 SNRNP200 ATP5F1A | 7.49e-05 | 1474 | 260 | 37 | int:TRIM28 |
| Interaction | LRRC31 interactions | ACACA CCT3 ITGB4 PI4KA NUP210 GCN1 CAD MYO1B LTN1 SNRNP200 NEURL4 | 7.56e-05 | 205 | 260 | 11 | int:LRRC31 |
| Interaction | HAPSTR1 interactions | HBS1L CCT3 CNST AASDHPPT DBN1 FREM2 PI4KA FDXR DDX23 HAX1 GCN1 VCPIP1 CARM1 CASP8AP2 CAD IPO8 ESYT1 PPP4R4 GTF3C1 NANS SLC25A13 SMARCD2 DCTN4 ATP2A3 ATP5F1A | 7.69e-05 | 829 | 260 | 25 | int:HAPSTR1 |
| Interaction | RHOA interactions | BRIX1 EPPK1 CFTR ANKS1B DGKQ NDUFS6 FAT1 MIA2 PIK3R2 PI4KA SYNE2 NUP210 DDX54 MCF2L GCN1 IGSF3 NPC1 CAD SLC4A7 ESYT1 RTN4 UPF1 HDAC7 AKAP12 VPS13D IPO9 LLGL1 SEC11A LAMTOR3 KIRREL1 MACF1 MX2 | 7.83e-05 | 1199 | 260 | 32 | int:RHOA |
| Interaction | MOB3C interactions | EPPK1 ACACA CCT3 AIMP1 ACLY MIA2 AHCY GCN1 RANBP2 CAD SLC4A7 ESYT1 CWC22 KANK2 GTF3C1 | 8.31e-05 | 364 | 260 | 15 | int:MOB3C |
| Interaction | DUSP2 interactions | 8.46e-05 | 81 | 260 | 7 | int:DUSP2 | |
| Interaction | FBXO2 interactions | CNTNAP3B CDHR2 CNTNAP3 SYNE2 NUP210 CNTN1 IGSF3 NPC1 COL12A1 SLC4A7 LAMA5 LAMB2 KPTN LRIG1 SEC11A AGRN | 9.41e-05 | 411 | 260 | 16 | int:FBXO2 |
| Interaction | MTDH interactions | BRIX1 OBSCN DBN1 PTCH1 NUP210 PWP2 DDX54 LOXL4 ALOX5 NPC1 SYNE1 LAMA5 IPO9 RNF2 FANCI TBK1 DDX21 ATP2A1 | 1.06e-04 | 505 | 260 | 18 | int:MTDH |
| Interaction | SIGLECL1 interactions | 1.10e-04 | 113 | 260 | 8 | int:SIGLECL1 | |
| Interaction | DUSP26 interactions | 1.11e-04 | 59 | 260 | 6 | int:DUSP26 | |
| Interaction | STIP1 interactions | BRIX1 ACACA CCT3 AIMP1 ACLY NPHP4 ME1 PI4KA NUP210 PWP2 HAX1 GCN1 CARM1 RANBP2 CAD IPO8 COPZ1 ESYT1 UPF1 DENND4C ADGB IPO9 FANCI SLC25A13 TBK1 EIF3B DDX21 SNRNP200 | 1.12e-04 | 1006 | 260 | 28 | int:STIP1 |
| Interaction | DYNC1I2 interactions | BRIX1 CCT3 CFTR DBN1 NDUFS6 CARM1 APRT PAPSS1 ARAF AKAP12 RNF2 EIF3B DCTN4 | 1.28e-04 | 295 | 260 | 13 | int:DYNC1I2 |
| Interaction | PROKR1 interactions | 1.36e-04 | 21 | 260 | 4 | int:PROKR1 | |
| Interaction | EGLN3 interactions | EPOR DNAJB11 HBS1L ACACA CCT3 CFTR DLGAP5 AASDHPPT DBN1 RMI1 PIK3R2 PI4KA MTMR3 HAX1 GCN1 CARM1 RANBP2 CAD IPO8 COPZ1 ISOC1 MYO1B APRT ARAF LLGL1 GTF3C1 FEZ2 FANCI SLC25A13 TBK1 DCTN4 ATP5F1A MYBL2 | 1.46e-04 | 1296 | 260 | 33 | int:EGLN3 |
| Interaction | MAPK6 interactions | CCT3 USP11 DBN1 NDUFS6 HAX1 CNTN1 AMPH CAD RTN4 IPO9 FANCI SLC25A13 NEURL4 ATP5F1A CDH13 TUBAL3 MYBL2 | 1.53e-04 | 474 | 260 | 17 | int:MAPK6 |
| Interaction | SEC11B interactions | 1.66e-04 | 2 | 260 | 2 | int:SEC11B | |
| Interaction | RBM46 interactions | 1.68e-04 | 9 | 260 | 3 | int:RBM46 | |
| Interaction | KCTD9 interactions | CCT3 ACLY TASOR2 EPM2AIP1 GCN1 TEPSIN RBPMS CAD DDX21 SNRNP200 ATP5F1A | 1.72e-04 | 225 | 260 | 11 | int:KCTD9 |
| Interaction | HDAC11 interactions | 1.80e-04 | 154 | 260 | 9 | int:HDAC11 | |
| Interaction | ZNF598 interactions | HBS1L EPPK1 CCT3 AIMP1 USP11 DBN1 NUP210 GCN1 CAD IPO8 TRMT1 AKAP12 SLC25A13 EIF3B MAP2K3 ATP5F1A | 1.80e-04 | 435 | 260 | 16 | int:ZNF598 |
| Interaction | RAB11A interactions | USP11 CFTR PTCH1 ABCB1 TYRP1 PI4KA SYNE2 STK24 CARM1 SLC4A7 CRACR2A ESYT1 RTN4 SCYL3 KANK2 SLC1A1 ARAF DENND4C AKAP12 LLGL1 KIRREL1 DCTN4 ATP5F1A DOP1A | 2.02e-04 | 830 | 260 | 24 | int:RAB11A |
| Interaction | NPY2R interactions | 2.07e-04 | 66 | 260 | 6 | int:NPY2R | |
| Interaction | RAB7A interactions | CALCOCO2 KIF1A COG3 NDUFS6 TMEM161A PIK3R2 PI4KA SYNE2 DDX54 NPC1 SLC4A7 SZT2 ESYT1 RTN4 SCYL3 APRT SLC1A1 DENND4C AKAP12 VPS13D LRIG1 LAMTOR3 DCTN4 ATP2A1 ATP5F1A | 2.16e-04 | 886 | 260 | 25 | int:RAB7A |
| Interaction | SLC15A3 interactions | CALCOCO2 DNAJB11 NUP210 HAX1 GCN1 CAD IPO8 IPO9 FANCI LTN1 ATP5F1A | 2.42e-04 | 234 | 260 | 11 | int:SLC15A3 |
| Interaction | FBXO22 interactions | DCHS2 ACACA OBSCN ME1 SLITRK1 NCBP3 KMT2C FBXO22 APEX2 KIF19 DDX54 DDX23 RTN4 ARAF VPS13D GTF3C1 SLC25A13 ATP2A3 | 2.43e-04 | 540 | 260 | 18 | int:FBXO22 |
| Interaction | BIRC3 interactions | CALCOCO2 BRIX1 CCT3 AIMP1 ACLY DDX42 DBN1 NUP210 PWP2 DDX54 AHCY HAX1 GCN1 RANBP2 CAD IPO8 PITRM1 ESYT1 SYNE1 RTN4 MYO1B UPF1 CWC22 IPO9 RNF2 GTF3C1 FANCI SLC25A13 SEC11A EIF3B DDX21 SNRNP200 ATP5F1A | 2.48e-04 | 1334 | 260 | 33 | int:BIRC3 |
| Interaction | KBTBD4 interactions | ACACA DLGAP5 PRUNE1 FDPS AHCY CARM1 RANBP2 SLC4A7 ANK2 ARAF AKAP12 DCTN4 DDX21 | 2.50e-04 | 316 | 260 | 13 | int:KBTBD4 |
| Interaction | MYH10 interactions | CALCOCO2 ACACA USP11 CFTR NPHP4 PIK3R2 DDX23 NPC1 ESYT1 XPC LLGL1 LTN1 EIF3B DCTN4 | 2.52e-04 | 359 | 260 | 14 | int:MYH10 |
| Interaction | SHANK3 interactions | CCT3 ACLY ANKS1B DBN1 NPHP4 TASOR2 FDPS PI4KA CNTN1 AMPH ANK2 SYNE1 RTN4 SCYL3 SPTBN4 MACF1 RAPGEF2 | 2.61e-04 | 496 | 260 | 17 | int:SHANK3 |
| Interaction | TMEM41B interactions | 2.62e-04 | 162 | 260 | 9 | int:TMEM41B | |
| Interaction | CUL7 interactions | BRIX1 DNAJB11 EPPK1 CCT3 ACLY DDX42 ABCB1 APEX2 NDUFAF7 SYNE2 NUP210 PWP2 AHCY DDX23 GCN1 RANBP2 CAD PCDHGA3 MYO1B APRT MACF1 DDX21 SNRNP200 ATP5F1A | 2.63e-04 | 845 | 260 | 24 | int:CUL7 |
| Interaction | DUSP16 interactions | KIF1A TASOR2 NXF2 NAV1 HAX1 CAD SZT2 NCKAP5L DENND4C SNRNP200 TUBAL3 | 2.70e-04 | 237 | 260 | 11 | int:DUSP16 |
| Interaction | SNAI1 interactions | BRIX1 ZBTB48 CCT3 USP11 ACLY RMI1 FBXO22 GCN1 CAD IPO8 UPF1 IPO9 RNF2 SLC25A13 INTS4 DDX21 NEURL4 ATP5F1A | 2.77e-04 | 546 | 260 | 18 | int:SNAI1 |
| Interaction | NPTN interactions | USP11 SARM1 INTS1 COG3 PI4KA GCN1 CNTN1 IPO8 FASTKD1 LTN1 ATP2A1 DOP1A | 2.79e-04 | 278 | 260 | 12 | int:NPTN |
| Interaction | MECP2 interactions | BRIX1 DNAJB11 INTS1 DDX42 DBN1 PWP2 DDX54 DDX23 HAX1 GCN1 ARHGEF6 RANBP2 CAD SYNE1 HECTD4 MYO1B CHD7 XPC UPF1 CWC22 LLGL1 GTF3C1 SLC25A13 SEC11A XPNPEP3 INTS4 MACF1 SMARCD2 EIF3B DDX21 AGRN SNRNP200 | 2.83e-04 | 1287 | 260 | 32 | int:MECP2 |
| Interaction | MORN3 interactions | 2.86e-04 | 70 | 260 | 6 | int:MORN3 | |
| Interaction | HCN3 interactions | 3.24e-04 | 11 | 260 | 3 | int:HCN3 | |
| Interaction | ASIC4 interactions | 3.54e-04 | 134 | 260 | 8 | int:ASIC4 | |
| GeneFamily | Cadherin related | 1.71e-05 | 17 | 172 | 4 | 24 | |
| GeneFamily | DEAD-box helicases | 4.70e-05 | 42 | 172 | 5 | 499 | |
| GeneFamily | ATPases Ca2+ transporting | 6.81e-05 | 9 | 172 | 3 | 1209 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 5.33e-04 | 4 | 172 | 2 | 1252 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.92e-04 | 161 | 172 | 7 | 593 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.67e-03 | 25 | 172 | 3 | 504 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.43e-03 | 8 | 172 | 2 | 939 | |
| GeneFamily | Fibulins | 2.43e-03 | 8 | 172 | 2 | 556 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | TBC1D9B SARM1 INTS1 DBN1 FDXR NUP210 IGSF3 CAD ESYT1 LAMA5 LAMB2 XPC CLSTN1 MAP2K3 AGRN | 1.33e-07 | 276 | 261 | 15 | M3063 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | ACACA KATNB1 DBN1 ABCB1 MCF2L RANBP2 RBPMS TRMT1 LAMA5 ISOC1 LAMB2 MACF1 ATP2A3 AGRN | 9.11e-07 | 279 | 261 | 14 | M16867 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DLGAP5 DDX42 FAT1 MIA2 SYNE2 MTMR3 DENND5A DMD STK24 RANBP2 AMPH RBPMS SLC4A7 MYO1B R3HDM2 ZMIZ1 C2CD3 MTAP RNF2 LRIG1 SLC25A13 LTN1 MACF1 RAPGEF2 DDX21 | 1.75e-06 | 856 | 261 | 25 | M4500 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NMNAT2 TBC1D9B KIF1A ACLY PTCH1 ME1 EPM2AIP1 KMT2C PI4KA SYNE2 ANKRD12 HAX1 RANBP2 SLC4A7 TPRG1L RTN4 HECTD4 ISOC1 CHD7 XPC ZMIZ1 RNF2 GTF3C1 PNMA8A ATP2A3 | 9.92e-06 | 946 | 261 | 25 | M39169 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | EPOR HBS1L GLT8D1 CCT3 AIMP1 USP11 ACLY AASDHPPT ENOPH1 FDPS PWP2 DDX23 ALDH6A1 STK24 CASP8AP2 RANBP2 CAD RTN4 XPC UPF1 PAPSS1 HDAC7 ARAF OXCT1 FEZ2 TBK1 SEC11A LAMTOR3 EIF3B DCTN4 RAPGEF2 DDX21 | 1.07e-05 | 1399 | 261 | 32 | M535 |
| Coexpression | GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN | HBS1L LAYN SDC4 RBPMS SLC4A7 ATP10A ZC3H12C RAPGEF2 DDX21 MX2 | 1.09e-05 | 175 | 261 | 10 | M6720 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | DLGAP5 PIK3R2 NAV1 CAD SLC4A8 IPO8 TRMT1 PAPSS1 IPO9 KIRREL1 | 1.95e-05 | 187 | 261 | 10 | M6807 |
| Coexpression | P53_DN.V1_UP | 2.67e-05 | 194 | 261 | 10 | M2698 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_1_DN | KATNB1 ABCB1 MCF2L RANBP2 RBPMS TRMT1 LAMA5 ISOC1 LAMB2 ATP2A3 AGRN | 2.91e-05 | 238 | 261 | 11 | M18841 |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | ENOPH1 NDUFS6 APEX2 FDPS FDXR AHCY ALDH6A1 NPC1 SLC4A7 RTN4 APRT GTF3C1 MACF1 SMARCD2 PCDHGC3 SNRNP200 | 3.16e-05 | 484 | 261 | 16 | M14665 |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | ACACA CCT3 KCTD11 CIITA FDPS SLC4A7 MTAP SEC11A EIF3B MAP2K3 | 3.18e-05 | 198 | 261 | 10 | M8628 |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_UP | CNTNAP3B DBN1 MTMR3 DENND5A ALOX5 YIPF6 VCPIP1 CHD7 UPF1 LIMK2 | 3.32e-05 | 199 | 261 | 10 | M5530 |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN | EPPK1 PPCDC PTCH1 KMT2C PIK3R2 TRMT1 GTF3C1 FEZ2 RAPGEF2 NEURL4 | 3.46e-05 | 200 | 261 | 10 | M3579 |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP | HBS1L GLT8D1 ACLY DDX54 HAX1 STON1 RTN4 SLC25A13 DDX21 MYBL2 | 3.46e-05 | 200 | 261 | 10 | M5061 |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | TBC1D9B INTS1 NPHP4 ALDH6A1 TRMT1 VPS13D ARSA XPNPEP3 MX2 ABHD11 | 3.46e-05 | 200 | 261 | 10 | M9002 |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 4.11e-05 | 20 | 261 | 4 | MM17053 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.56e-05 | 166 | 261 | 9 | M6826 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.66e-05 | 40 | 261 | 5 | M5887 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | ACLY DLGAP5 ME1 PRUNE1 SYNE2 DENND5A CASP8AP2 ANK2 FASTKD1 LAMA5 CHD7 SLC1A1 ATP10A IPO9 OXCT1 NANS SLC25A13 TBK1 MACF1 MAP2K3 PCDHGC3 | 4.80e-05 | 790 | 261 | 21 | M12490 |
| Coexpression | HORTON_SREBF_TARGETS | 8.73e-05 | 24 | 261 | 4 | MM1329 | |
| Coexpression | HORTON_SREBF_TARGETS | 8.73e-05 | 24 | 261 | 4 | M3009 | |
| Coexpression | KRAS.50_UP.V1_DN | 1.03e-04 | 47 | 261 | 5 | M2876 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | STK36 GLT8D1 EPPK1 USP11 LRRC10B KATNB1 PALMD CFAP54 FDXR SYNE2 KIF19 DMD TPRG1L SYNE1 C11orf16 CLSTN1 PAPSS1 WDR19 ADGB HHLA2 LIMK2 MTF1 NANS XPNPEP3 ABHD11 | 1.04e-04 | 1093 | 261 | 25 | M41649 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | CCT3 ACLY DLGAP5 DDX42 ENOPH1 PI4KA NUP210 AHCY GCN1 CAD FASTKD1 GINS4 CHD7 APRT FANCI EIF3B SNRNP200 | 1.52e-04 | 612 | 261 | 17 | M4772 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | INTS1 DENND4B DENND5A TEPSIN SZT2 NCKAP5L HDAC7 LIMK2 LLGL1 EIF3B AGRN NEURL4 | 1.61e-04 | 338 | 261 | 12 | M17094 |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 1.69e-04 | 197 | 261 | 9 | M8271 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.69e-04 | 197 | 261 | 9 | M8983 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | HBS1L USP11 ANKS1B ARHGEF6 SYNE1 ZNF711 VPS13D CATSPERB SNRNP200 | 1.69e-04 | 197 | 261 | 9 | M5475 |
| Coexpression | GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN | 1.75e-04 | 198 | 261 | 9 | M7916 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | OBSCN PTCH1 OLFML2A NFATC4 DMD COL6A3 RBPMS COL12A1 LAMA5 LAMB2 KANK2 POSTN KIRREL1 CDH13 MX2 | 1.81e-04 | 505 | 261 | 15 | M39167 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.82e-04 | 199 | 261 | 9 | M7254 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP | 1.82e-04 | 199 | 261 | 9 | M9918 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN | 1.89e-04 | 200 | 261 | 9 | M7178 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 1.89e-04 | 200 | 261 | 9 | M9768 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN | 1.89e-04 | 200 | 261 | 9 | M6020 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN | 1.89e-04 | 200 | 261 | 9 | M7440 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | DNAJB11 DLGAP5 FDPS GINS4 ATP10A AKAP12 C2CD3 SLC25A13 ATP2A3 | 1.89e-04 | 200 | 261 | 9 | M7449 |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN | 1.89e-04 | 200 | 261 | 9 | M4057 | |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_UP | 1.89e-04 | 200 | 261 | 9 | M6803 | |
| Coexpression | GSE17721_12H_VS_24H_POLYIC_BMDC_DN | 1.89e-04 | 200 | 261 | 9 | M4102 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | CNNM2 TBC1D9B AASDHPPT PRUNE1 APEX2 FDPS PI4KA SYNE2 COPZ1 SYNE1 UPF1 CLSTN1 PAPSS1 VPS13D GTF3C1 SLC22A1 | 1.99e-04 | 567 | 261 | 16 | M16909 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 2.01e-04 | 12 | 261 | 3 | M47983 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 2.09e-04 | 85 | 261 | 6 | M1723 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 2.09e-04 | 85 | 261 | 6 | MM720 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LPS_UP | CFTR DDX42 DENND5A MCF2L SDC4 CRACR2A LIMK2 JRK PNMA8A ZC3H12C RAPGEF2 MAP2K3 MX2 | 2.38e-04 | 406 | 261 | 13 | M9673 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | CCT3 ACLY DBN1 PRUNE1 OLFML2A KLHL30 PIK3R2 OSBPL7 SLC4A8 CLSTN1 PAPSS1 ATP10A HDAC7 ZNF711 IPO9 OXCT1 LLGL1 JRK PNMA8A SNRNP200 CDH13 | 2.53e-04 | 891 | 261 | 21 | M45033 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 2.82e-04 | 167 | 261 | 8 | M6699 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | GABRB3 TTYH1 KIF1A ACLY GLYCTK SLITRK1 DENND4B SYNE2 NUP210 DMD ALDH6A1 CASP8AP2 COL6A3 RANBP2 ANK2 TNC EXOSC1 CHD7 CWC22 SLC1A1 WDR19 POSTN OXCT1 MTAP RASAL3 SLC25A13 ZC3H12C DOP1A | 2.01e-05 | 983 | 254 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | GABRB3 TTYH1 GLT8D1 KIF1A USP11 GLYCTK DGKQ SLITRK1 FAT1 DENND4B NUP210 ANKRD12 DMD MCF2L ARHGEF6 SLC4A8 ANK2 HECTD4 LAMB2 CHD7 C2CD3 OXCT1 DOP1A | 2.58e-05 | 732 | 254 | 23 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 CFTR OBSCN FREM2 FAT1 PKHD1 DMD CNTN1 GALNTL6 ATP13A4 COL12A1 HMCN1 OTOG | 8.21e-11 | 184 | 263 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 CFTR OBSCN FREM2 FAT1 PKHD1 DMD CNTN1 GALNTL6 ATP13A4 COL12A1 HMCN1 OTOG | 8.21e-11 | 184 | 263 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STK36 CFTR OBSCN FREM2 FAT1 PKHD1 DMD CNTN1 GALNTL6 ATP13A4 COL12A1 HMCN1 OTOG | 8.21e-11 | 184 | 263 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | SPEGNB PTCH1 FAT1 DMD RBPMS TNC SYNE1 LAMB2 KANK2 POSTN OXCT1 PNMA8A DCLK3 | 2.32e-10 | 200 | 263 | 13 | 593bf6a7c557437db9a9249a5058a46014179ef6 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | LAYN SPEGNB PTCH1 FAT1 DMD COL6A3 RBPMS TNC SYNE1 LAMB2 KANK2 POSTN | 2.70e-09 | 199 | 263 | 12 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | LAYN SPEGNB PTCH1 FAT1 DMD COL6A3 RBPMS TNC SYNE1 LAMB2 KANK2 POSTN | 2.86e-09 | 200 | 263 | 12 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | ANKS1B SPEGNB PTCH1 FAT1 DMD COL6A3 RBPMS TNC SYNE1 KANK2 POSTN DCLK3 | 2.86e-09 | 200 | 263 | 12 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EPPK1 PALMD ITGB4 SDC4 IGSF3 ISOC1 CLSTN1 POSTN DCTN4 PCDHGC3 CDH13 | 1.03e-08 | 179 | 263 | 11 | 8001db3044e8657980e24422377c4fdb0d7b323e |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ANKS1B PTCH1 MAGI2 FAT1 DMD COL6A3 RBPMS TNC SYNE1 KANK2 POSTN | 1.45e-08 | 185 | 263 | 11 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | LAYN SPEGNB PTCH1 FAT1 DMD COL6A3 RBPMS TNC SYNE1 KANK2 POSTN | 3.24e-08 | 200 | 263 | 11 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | TTYH1 ABCB1 FREM2 KLHL30 STON1 TPRG1L TNC LAMB2 HDAC7 ARAF RBPMS2 | 3.24e-08 | 200 | 263 | 11 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CNNM2 SPEGNB FAT1 DMD COL6A3 RBPMS TNC SYNE1 MYO1B KANK2 POSTN | 3.24e-08 | 200 | 263 | 11 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPEGNB PTCH1 FAT1 DMD RBPMS SLC4A7 TNC SYNE1 KANK2 POSTN DCLK3 | 3.24e-08 | 200 | 263 | 11 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | DBN1 ITGB4 OSBPL7 LOXL4 COL12A1 LAMA5 LAMB2 KANK2 SYCE1L AGRN | 8.19e-08 | 172 | 263 | 10 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | OLFML2A TYRP1 CNTN1 COL6A3 PCDHGA3 KANK2 HMCN1 PNMA8A CATSPERB PCDHGC3 | 1.07e-07 | 177 | 263 | 10 | 8220cc2fc0ee8764a67a3be51d75248be2453040 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | OLFML2A TYRP1 CNTN1 COL6A3 PCDHGA3 KANK2 HMCN1 PNMA8A CATSPERB PCDHGC3 | 1.07e-07 | 177 | 263 | 10 | 7617270f49cd6b7ba66db72d20560cee985012b2 |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.14e-07 | 135 | 263 | 9 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NFATC4 KLHL30 SYNE2 COL6A3 STON1 LAMA5 LAMB2 NCKAP5L LRIG1 RBPMS2 | 1.62e-07 | 185 | 263 | 10 | 38486b69c48dc5e1c4e1488208fa8954a973eccb |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NFATC4 KLHL30 SYNE2 COL6A3 STON1 LAMA5 LAMB2 NCKAP5L LRIG1 RBPMS2 | 1.62e-07 | 185 | 263 | 10 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SPEGNB TYRP1 DMD SPOCD1 RBPMS COL12A1 STON1 TNC KANK2 AKAP12 | 1.88e-07 | 188 | 263 | 10 | 879de94924de978478696fc7838e05a4d795b905 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | SPEGNB TYRP1 DMD SPOCD1 RBPMS COL12A1 STON1 TNC KANK2 AKAP12 | 1.97e-07 | 189 | 263 | 10 | ab7ece0a517499b70b7754720d3e434765363af6 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-07 | 189 | 263 | 10 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-07 | 191 | 263 | 10 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CNTNAP3 SPEGNB DBN1 FREM2 DMD RBPMS KANK2 AKAP12 POSTN RBPMS2 | 2.29e-07 | 192 | 263 | 10 | d0fb6885f023d55a2b7984c99db9c6463258f788 |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.40e-07 | 193 | 263 | 10 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC10B OLFML2A KLHL30 DMD RBPMS LAMA5 KANK2 RBPMS2 KIRREL1 ATP2A3 | 2.52e-07 | 194 | 263 | 10 | bf34737ae2dc218f890fbb9201c308b324415749 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC10B OLFML2A KLHL30 DMD RBPMS LAMA5 KANK2 RBPMS2 KIRREL1 ATP2A3 | 2.52e-07 | 194 | 263 | 10 | b35e33439b6d3b5d69147e617224d2c8fd056223 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC10B OLFML2A KLHL30 DMD RBPMS LAMA5 KANK2 RBPMS2 KIRREL1 ATP2A3 | 2.52e-07 | 194 | 263 | 10 | 4ebed7a6731b88c8359860072cbeba355a7e90ac |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.77e-07 | 196 | 263 | 10 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 197 | 263 | 10 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-07 | 197 | 263 | 10 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | OBSCN ANKS1B PALMD ITGB4 CYP2W1 OLFML2A FAT1 LOXL4 CROT PLCH2 | 2.90e-07 | 197 | 263 | 10 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-07 | 199 | 263 | 10 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 LAYN FAT1 COL12A1 TNC SYNE1 AKAP12 SYCE1L LIMK2 KIRREL1 | 3.18e-07 | 199 | 263 | 10 | b9338b739162cd8e5661c9a4dcb41a31219b5723 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 LAYN FAT1 COL12A1 TNC SYNE1 AKAP12 SYCE1L LIMK2 KIRREL1 | 3.18e-07 | 199 | 263 | 10 | c972d3036151403f26fa9d6271520639c281ab84 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.18e-07 | 199 | 263 | 10 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 200 | 263 | 10 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-07 | 160 | 263 | 9 | 955acb023ce4ccfac5073c9d693db87db3856187 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 173 | 263 | 9 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 173 | 263 | 9 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-06 | 183 | 263 | 9 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 184 | 263 | 9 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 185 | 263 | 9 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-06 | 185 | 263 | 9 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 187 | 263 | 9 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.78e-06 | 187 | 263 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.78e-06 | 187 | 263 | 9 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-06 | 188 | 263 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.95e-06 | 189 | 263 | 9 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-06 | 191 | 263 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 192 | 263 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-06 | 193 | 263 | 9 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.31e-06 | 193 | 263 | 9 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC10B OLFML2A NFATC4 KLHL30 RBPMS STON1 LAMA5 C11orf16 RBPMS2 | 2.62e-06 | 196 | 263 | 9 | 184104cbea0461dd2757668ab9755948ac7b585a |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC10B OLFML2A NFATC4 KLHL30 RBPMS STON1 LAMA5 C11orf16 RBPMS2 | 2.62e-06 | 196 | 263 | 9 | 8114e98923096c54b6834f21550c3061bab6773d |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.74e-06 | 197 | 263 | 9 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-06 | 198 | 263 | 9 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.85e-06 | 198 | 263 | 9 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.97e-06 | 199 | 263 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.97e-06 | 199 | 263 | 9 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.10e-06 | 200 | 263 | 9 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 200 | 263 | 9 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.57e-06 | 162 | 263 | 8 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 164 | 263 | 8 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 164 | 263 | 8 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-06 | 164 | 263 | 8 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-06 | 164 | 263 | 8 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.28e-06 | 168 | 263 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 8.28e-06 | 171 | 263 | 8 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | Healthy/Control-MAIT|Healthy/Control / Disease group and Cell class | 9.02e-06 | 173 | 263 | 8 | 56247c1e07477a8922fe2e3950ae05e2217fd77c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.10e-06 | 82 | 263 | 6 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 174 | 263 | 8 | a8bd1fa08bf061a627529a38e5a23a68b6d80697 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 174 | 263 | 8 | 7f8f6a15a823809effd37c1a5b09ef19b6d67755 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-06 | 174 | 263 | 8 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-06 | 175 | 263 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 176 | 263 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.16e-05 | 179 | 263 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 181 | 263 | 8 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.30e-05 | 182 | 263 | 8 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 182 | 263 | 8 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 183 | 263 | 8 | 6b5eef96b28911c752a8b6c0975918c4572cec38 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-05 | 185 | 263 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | EPPK1 ZBTB48 PRUNE1 OLFML2A ATP2C2 DDX54 DENND5A ALDH6A1 VCPIP1 LAMB2 VPS13D KIRREL1 | 2.72e-06 | 196 | 259 | 12 | 5827_DN |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | CDHR2 PTCH1 CYP2W1 NPHS2 NUP210 MTMR3 MYO1B ATP10A PPP4R4 ADGB LLGL1 SNRNP200 | 3.03e-06 | 198 | 259 | 12 | 5067_UP |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; PC3; HT_HG-U133A | CNNM2 PALMD ATP2C2 MTMR3 MCF2L IPO8 ATP10A PPP4R4 TGM4 LRIG1 KRT37 MX2 | 3.36e-06 | 200 | 259 | 12 | 4242_UP |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | HBS1L CNNM2 INTS1 PTCH1 VCPIP1 STON1 SZT2 SCYL3 MYO1B WDR19 MTAP | 5.24e-06 | 174 | 259 | 11 | 1019_UP |
| Drug | magnesium | NMNAT2 CNNM2 KIF1A CFTR DGKQ AASDHPPT ENOPH1 ABCB1 APEX2 PIK3R2 FDPS ATP2C2 DENND5A ALOX5 RANBP2 CAD PNMT TNC RTN4 LAMA5 LAMB2 MYO1B UPF1 APRT PAPSS1 ARSA NANS TBK1 XPNPEP3 ATP2A1 ATP2A3 TRPV5 ATP5F1A TUBAL3 | 7.90e-06 | 1325 | 259 | 34 | CID000000888 |
| Drug | AC1L1KMJ | CFTR DBN1 APEX2 NFATC4 PIK3R2 PI4KA CNTN1 COL6A3 COL12A1 ANK2 LAMA5 LAMB2 MYO1B SLC1A1 AKAP12 SPTBN4 MACF1 TUBAL3 | 9.71e-06 | 476 | 259 | 18 | CID000030956 |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | BRIX1 TMEM161A NUP210 PWP2 CAD SLC4A7 UPF1 XPNPEP3 ZNF500 EIF3B ATP2A3 | 1.15e-05 | 189 | 259 | 11 | 1171_DN |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | CDH20 AMPH C11orf16 ATP10A PRX TGM4 LLGL1 SLC22A1 HAS1 MX2 DOP1A | 1.54e-05 | 195 | 259 | 11 | 3804_UP |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | DCHS2 CNNM2 CDHR2 NPHP4 CYP2W1 C11orf16 ATP10A HDAC7 MACF1 ATP2A1 SNRNP200 | 1.54e-05 | 195 | 259 | 11 | 2394_UP |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A | EPOR KATNB1 PALMD NUP210 SLC4A7 XPC KPTN LIMK2 VPS13D MTAP DOP1A | 1.62e-05 | 196 | 259 | 11 | 7259_DN |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; HL60; HG-U133A | CNNM2 PRUNE1 TMEM161A APEX2 NUP210 RANBP2 SLC4A7 SZT2 KPTN MACF1 ATP2A3 | 1.70e-05 | 197 | 259 | 11 | 1992_DN |
| Drug | 9H-carbazole | 2.40e-05 | 51 | 259 | 6 | CID000006854 | |
| Drug | tiapamil | 2.84e-05 | 6 | 259 | 3 | CID000042106 | |
| Disease | Colorectal Carcinoma | CALCOCO2 ACACA CFTR OBSCN ABCB1 KMT2C FAT1 PKHD1 DMD CNTN1 CAD ANK2 SYNE1 RTN4 MYO1B ZMIZ1 AKAP12 POSTN SNRNP200 | 1.24e-05 | 702 | 254 | 19 | C0009402 |
| Disease | nevus count, cutaneous melanoma | 1.41e-05 | 91 | 254 | 7 | EFO_0000389, EFO_0004632 | |
| Disease | coronary artery disease | HBS1L CNNM2 LAYN KIF1A LRRC10B CFTR NUP210 PKHD1 DENND5A MCF2L STK24 NPC1 COL6A3 STON1 TTC41P HCN4 HECTD4 LAMB2 R3HDM2 KANK2 AKAP12 MTAP SLC22A1 RBPMS2 RAPGEF2 CDH13 | 1.51e-05 | 1194 | 254 | 26 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | EPOR TBC1D9B OBSCN DBN1 COG3 ABCB1 TMEM161A CDH20 MIA2 SYNE2 MTMR3 DMD SPOCD1 ANK2 SYNE1 ZMIZ1 APRT HDAC7 ARAF AKAP12 LLGL1 MACF1 ATP2A3 DOP1A | 2.16e-05 | 1074 | 254 | 24 | C0006142 |
| Disease | nephrotic syndrome (implicated_via_orthology) | 4.98e-05 | 24 | 254 | 4 | DOID:1184 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Sarcoma | 5.19e-05 | 47 | 254 | 5 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 7.02e-05 | 50 | 254 | 5 | C0238198 | |
| Disease | cutaneous melanoma | 8.84e-05 | 121 | 254 | 7 | EFO_0000389 | |
| Disease | waist circumference | CFTR ANKS1B DGKQ SYNE2 PKHD1 NAV1 HAX1 DMD HECTD4 ZMIZ1 CWC22 IPO9 ATP2A1 | 9.89e-05 | 429 | 254 | 13 | EFO_0004342 |
| Disease | Nephronophthisis | 1.69e-04 | 13 | 254 | 3 | C0687120 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 1.69e-04 | 13 | 254 | 3 | C0750905 | |
| Disease | Amino Acid Metabolism, Inborn Errors | 1.69e-04 | 13 | 254 | 3 | C0002514 | |
| Disease | Brody myopathy (implicated_via_orthology) | 2.20e-04 | 3 | 254 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | cysteine-rich hydrophobic domain-containing protein 2 measurement | 2.20e-04 | 3 | 254 | 2 | EFO_0801510 | |
| Disease | pyruvate kinase PKLR measurement | 2.20e-04 | 3 | 254 | 2 | EFO_0801982 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.46e-04 | 101 | 254 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | hypertension | CNNM2 LRRC10B SARM1 GML COL6A3 SLC4A7 STON1 SZT2 HECTD4 CDH13 | 3.56e-04 | 307 | 254 | 10 | EFO_0000537 |
| Disease | Ullrich congenital muscular dystrophy 1 | 4.38e-04 | 4 | 254 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 4.38e-04 | 4 | 254 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | cholangiocarcinoma | 4.38e-04 | 4 | 254 | 2 | EFO_0005221 | |
| Disease | calcium-binding and coiled-coil domain-containing protein 2 measurement | 4.38e-04 | 4 | 254 | 2 | EFO_0802356 | |
| Disease | Ullrich congenital muscular dystrophy | 4.38e-04 | 4 | 254 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 4.38e-04 | 4 | 254 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 4.38e-04 | 4 | 254 | 2 | C1834674 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 4.38e-04 | 4 | 254 | 2 | cv:CN293514 | |
| Disease | Acute Erythroblastic Leukemia | 4.38e-04 | 4 | 254 | 2 | C0023440 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 4.38e-04 | 4 | 254 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Cannabis use, age at onset | 5.52e-04 | 19 | 254 | 3 | EFO_0004847, EFO_0007585 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 7.26e-04 | 5 | 254 | 2 | C0410190 | |
| Disease | Choledochal Cyst, Type I | 7.26e-04 | 5 | 254 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 7.26e-04 | 5 | 254 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 7.26e-04 | 5 | 254 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 7.26e-04 | 5 | 254 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 7.26e-04 | 5 | 254 | 2 | C1257799 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 7.26e-04 | 5 | 254 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 7.26e-04 | 5 | 254 | 2 | C0917713 | |
| Disease | Choledochal Cyst | 7.26e-04 | 5 | 254 | 2 | C0008340 | |
| Disease | sick sinus syndrome (is_implicated_in) | 7.26e-04 | 5 | 254 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 7.26e-04 | 5 | 254 | 2 | C1450051 | |
| Disease | reticulocyte count | HBS1L CNNM2 ACLY FAT1 CDH20 FDPS SYNE2 MTMR3 HAX1 SPOCD1 ALOX5 HECTD4 MYO1B KANK2 ARSA MTAP TBK1 LTN1 MAP2K3 MYBL2 | 7.77e-04 | 1045 | 254 | 20 | EFO_0007986 |
| Disease | response to anticonvulsant | 8.51e-04 | 85 | 254 | 5 | GO_0036277 | |
| Disease | aspartate aminotransferase measurement | HBS1L TBC1D9B OBSCN PTCH1 ABCB1 PRUNE1 CDH20 HMCN2 LOXL4 GCN1 SLC4A7 STON1 HECTD4 R3HDM2 CROT IPO9 ARSA SLC22A1 | 9.10e-04 | 904 | 254 | 18 | EFO_0004736 |
| Disease | Emery-Dreifuss muscular dystrophy | 1.08e-03 | 6 | 254 | 2 | cv:C0410189 | |
| Disease | EPILEPSY, CHILDHOOD ABSENCE, 1 | 1.08e-03 | 6 | 254 | 2 | C1838604 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.08e-03 | 6 | 254 | 2 | C0410189 | |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 1.08e-03 | 6 | 254 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | Muscular Dystrophy, Duchenne | 1.08e-03 | 6 | 254 | 2 | C0013264 | |
| Disease | PR interval | OBSCN MAGI2 FREM2 FAT1 SYNE2 RBPMS HCN4 LAMB2 ZMIZ1 RBPMS2 MACF1 CDH13 | 1.31e-03 | 495 | 254 | 12 | EFO_0004462 |
| Disease | Epilepsy, Absence, Atypical | 1.51e-03 | 7 | 254 | 2 | C0751124 | |
| Disease | Juvenile Absence Epilepsy | 1.51e-03 | 7 | 254 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 1.51e-03 | 7 | 254 | 2 | C4281785 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.51e-03 | 7 | 254 | 2 | C0751337 | |
| Disease | skeletal age | 1.51e-03 | 7 | 254 | 2 | EFO_0020898 | |
| Disease | Akinetic Petit Mal | 1.51e-03 | 7 | 254 | 2 | C0001890 | |
| Disease | Nephronophthisis, familial juvenile | 1.51e-03 | 7 | 254 | 2 | C1855681 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.51e-03 | 7 | 254 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Absence Seizure Disorder | 1.51e-03 | 7 | 254 | 2 | C4553705 | |
| Disease | Epilepsy, Minor | 1.51e-03 | 7 | 254 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 1.51e-03 | 7 | 254 | 2 | C0014553 | |
| Disease | Renal dysplasia and retinal aplasia | 1.51e-03 | 7 | 254 | 2 | cv:C0403553 | |
| Disease | intelligence, response to cranial radiation therapy | 1.76e-03 | 28 | 254 | 3 | EFO_0004337, EFO_0010950 | |
| Disease | Weight Gain | 1.92e-03 | 102 | 254 | 5 | C0043094 | |
| Disease | gait measurement | 1.95e-03 | 150 | 254 | 6 | EFO_0007680 | |
| Disease | hemoglobin A1 measurement | HBS1L CNNM2 CCT3 SYNE2 MTMR3 COPZ1 ZMIZ1 LRIG1 MTF1 MACF1 MAP2K3 SNRNP200 | 1.97e-03 | 520 | 254 | 12 | EFO_0007629 |
| Disease | Abnormality of the skeletal system | 2.00e-03 | 8 | 254 | 2 | C4021790 | |
| Disease | Endotoxemia | 2.00e-03 | 8 | 254 | 2 | C0376618 | |
| Disease | zinc-alpha-2-glycoprotein measurement | 2.00e-03 | 8 | 254 | 2 | EFO_0802228 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.00e-03 | 8 | 254 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | cutaneous melanoma, hair color | 2.02e-03 | 62 | 254 | 4 | EFO_0000389, EFO_0003924 | |
| Disease | reticulocyte measurement | HBS1L CNNM2 PPCDC FAT1 CDH20 SYNE2 MTMR3 SPOCD1 ALOX5 COPZ1 HECTD4 TRMT1 MYO1B KANK2 GARIN2 MTAP TBK1 LTN1 MYBL2 | 2.05e-03 | 1053 | 254 | 19 | EFO_0010700 |
| Disease | cervical cancer (is_implicated_in) | 2.16e-03 | 30 | 254 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | fish consumption measurement | 2.27e-03 | 64 | 254 | 4 | EFO_0010139 | |
| Disease | platelet component distribution width | HBS1L MIA2 NPC1 SLC4A7 COPZ1 SYNE1 LAMA5 ZMIZ1 HDAC7 MTF1 RBPMS2 MACF1 CATSPERB GGNBP1 ABHD11 | 2.45e-03 | 755 | 254 | 15 | EFO_0007984 |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.47e-03 | 108 | 254 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 2.55e-03 | 9 | 254 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.55e-03 | 9 | 254 | 2 | C0085548 | |
| Disease | CXCL1 measurement | 2.55e-03 | 9 | 254 | 2 | EFO_0010777 | |
| Disease | 2-hydroxystearate measurement | 2.55e-03 | 9 | 254 | 2 | EFO_0021059 | |
| Disease | Pulmonary Cystic Fibrosis | 2.55e-03 | 9 | 254 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 2.55e-03 | 9 | 254 | 2 | C1527396 | |
| Disease | Mental Retardation, X-Linked 1 | 2.60e-03 | 32 | 254 | 3 | C2931498 | |
| Disease | Ciliopathies | 2.67e-03 | 110 | 254 | 5 | C4277690 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 3.17e-03 | 10 | 254 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 3.17e-03 | 10 | 254 | 2 | EFO_0008321 | |
| Disease | serum alanine aminotransferase measurement | PTCH1 ABCB1 PRUNE1 CDH20 PIK3R2 NUP210 AHCY ALOX5 NPC1 COL12A1 STON1 HECTD4 LAMA5 CROT LTN1 SMARCD2 | 3.75e-03 | 869 | 254 | 16 | EFO_0004735 |
| Disease | peanut allergy measurement, parental genotype effect measurement | 3.86e-03 | 11 | 254 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | Basal cell carcinoma | 3.86e-03 | 11 | 254 | 2 | C0007117 | |
| Disease | Cystic Fibrosis | 3.86e-03 | 11 | 254 | 2 | C0010674 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.86e-03 | 11 | 254 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | response to virus | 3.86e-03 | 11 | 254 | 2 | GO_0009615 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 4.60e-03 | 12 | 254 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 28 measurement | 4.60e-03 | 12 | 254 | 2 | EFO_0020199 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 4.60e-03 | 12 | 254 | 2 | C0403553 | |
| Disease | brain disease (is_implicated_in) | 4.60e-03 | 12 | 254 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Liver carcinoma | ACACA ACLY DLGAP5 ME1 ABCB1 OLFML2A KMT2C FANCI SLC22A1 CDH13 MYBL2 | 4.75e-03 | 507 | 254 | 11 | C2239176 |
| Disease | melanoma | 4.77e-03 | 126 | 254 | 5 | EFO_0000756 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 5.41e-03 | 13 | 254 | 2 | C3501611 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 5.41e-03 | 13 | 254 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | short-term memory | 5.79e-03 | 83 | 254 | 4 | EFO_0004335 | |
| Disease | melanoma | 5.89e-03 | 248 | 254 | 7 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTLEEVLEPRTELVA | 156 | Q9H313 | |
| QPGVTISVLELAEID | 146 | Q6ZS92 | |
| VIVTSVPGQELEVEV | 706 | Q9BSJ8 | |
| AVLAAEPELQVGIDI | 116 | Q9NRN7 | |
| RRILQTGPIVTDEVE | 421 | Q96N23 | |
| ALDLEERATVTPGVE | 941 | Q9BZ76 | |
| RPQEADGIDSVIVVD | 176 | P55884 | |
| IPIAGTVVTRLDEIE | 496 | Q15052 | |
| DSEQGEAILPRISVI | 741 | P13569 | |
| TEGTLLDVIREPILQ | 146 | Q9H7T0 | |
| SAIQDIGLPLVEEET | 1221 | Q8N7X0 | |
| VSVAIEDLEPENGIL | 1526 | Q02952 | |
| PDGILVEVDLVQARL | 356 | P33076 | |
| GVQELESRVLVPGDL | 271 | Q4VNC1 | |
| ELVERLIAVDISPVE | 156 | Q8NFV4 | |
| VEEVDVGEIAPRTVV | 176 | Q12904 | |
| VEVGRDVTVPELREA | 111 | P22570 | |
| VLTGTVEEILNVDPV | 46 | O00468 | |
| PDVFVLRVRLEETGE | 91 | Q9BZ19 | |
| RDPVFVSLLGLIDEV | 191 | Q8TAV3 | |
| VERQEVELPSIEGLI | 801 | P52824 | |
| IPVGVVAVETRTVEL | 1981 | Q13085 | |
| QIIEEDAALVEIGPR | 221 | Q8TDN6 | |
| LGPVILEDVLIEVFR | 366 | Q5JWR5 | |
| SSVEEAVGDRVPVLL | 641 | Q9BSW2 | |
| ELRIISTITREVEPE | 681 | O94985 | |
| LETVRIFLTEQPLEG | 2866 | P11532 | |
| VTRDALTEPLAIVEG | 51 | Q9UBZ4 | |
| VEDVKLIISEGRPTI | 1291 | Q6UB98 | |
| GDIVTVVSPALLDRE | 306 | P55290 | |
| LESDVLVGRPRVEAQ | 81 | Q8N1I8 | |
| VALLAVTEPRIGISE | 636 | Q9UKL3 | |
| LDINTLTGEERVPVV | 2636 | Q9P2D1 | |
| KARDIVPGDIVEVAV | 141 | O14983 | |
| VEVAVGDKVPADIRI | 151 | O14983 | |
| RARDIVPGDIVEVAV | 141 | Q93084 | |
| IGDRIPADIRLTEVT | 196 | O75185 | |
| ESTEDPVIIERALIT | 106 | Q8N2F6 | |
| TGIEDRLQDGVPETI | 861 | O60312 | |
| AIVDVPVGEELLGRV | 136 | P25705 | |
| ALEPGQRVVVVDDLL | 116 | P07741 | |
| TRAEEPVEEAVIIPG | 456 | P49418 | |
| ADVVLGRVLEVTDLP | 861 | Q9Y2K5 | |
| GRVLEVTDLPEGITR | 866 | Q9Y2K5 | |
| LEEEVRTLFVSGLPV | 26 | Q6ZRY4 | |
| TILRAIEEGQPVLVS | 731 | Q86YV0 | |
| IGNIDVREPELEDLT | 406 | P49792 | |
| EEVRTLFVSGLPLDI | 21 | Q93062 | |
| GSLREEIQPGDIVII | 96 | Q13126 | |
| RELGLAESDIVDIPQ | 556 | Q9ULC6 | |
| RKPVEAESVEGVVRI | 61 | Q96HW7 | |
| VLGDAVPDEILIEAV | 91 | Q9Y450 | |
| SARVELRDVEPAVVG | 71 | Q0D2K2 | |
| VPVEQAVSVAIIDLL | 546 | Q15334 | |
| SEASPEVLGVNIEII | 1211 | O94822 | |
| LREIIGVVSQEPVLF | 466 | P08183 | |
| ESIETLIERIPDENG | 3541 | Q01484 | |
| EGVGRSTVLEEPVQE | 286 | Q7Z6G8 | |
| SIELILVEDVRVSPE | 886 | Q8TEM1 | |
| IEVGEGVNLSTIPRE | 71 | Q86V59 | |
| LVTERILQGAPEILD | 151 | Q86TP1 | |
| LTEVGLLDNPELRVV | 206 | Q8NEZ5 | |
| TVSEDVPIGTEIDLI | 2711 | Q14517 | |
| DELLDVVTVPSGELR | 251 | Q9NVI1 | |
| PVLVVLETETLDEAI | 421 | Q02252 | |
| TDGLAPVEVEELLRQ | 231 | Q9NP74 | |
| EVEAALAEIPGVRSV | 191 | Q96CN7 | |
| GRIPEEGLLEVQVEV | 426 | Q96JB6 | |
| ITKPDGIVEERRTVV | 216 | O00165 | |
| RLQPGEEVEIAELTT | 526 | Q8NEZ4 | |
| PEDVIKAIVVTDGER | 141 | P48163 | |
| ETPVAGLTIRDVLAV | 71 | Q86UL8 | |
| VVPLEDRVVSVGETV | 696 | Q96JA1 | |
| LEREVPGIEELLVSG | 1176 | Q9HCH0 | |
| EELVLRVQGPELISL | 1721 | Q8N201 | |
| ELLTRPEITVVEGEG | 61 | Q5YKI7 | |
| PVRTLRVEEVEDAIS | 211 | P53671 | |
| RGLTVVVAFRELVEP | 126 | P14324 | |
| QLTELPRDVTVELGR | 786 | Q8NDA2 | |
| REAEGEETELTTPVL | 196 | Q6UX15 | |
| LDIEPTIDLNRVLGE | 261 | O76014 | |
| SRVGETEELPEIRVD | 3636 | Q2LD37 | |
| LDIEPTIDLNRVLGE | 261 | O76015 | |
| VVTRNLPLVVEELLG | 181 | Q5SZK8 | |
| VESVRLNTPEELIVA | 66 | Q9BVA0 | |
| LLERPTDDSVEVAIG | 281 | Q9HCG8 | |
| AGLTEPVLIRLDVDT | 291 | Q8TDD1 | |
| LVEVLPVTEEGLREV | 246 | Q9C098 | |
| LTDRIVVIPGKVEEV | 231 | Q86X55 | |
| DILIDPIRVVQGDIG | 451 | Q86XP3 | |
| VLVATDVAARGLDIP | 551 | Q86XP3 | |
| GLEDVVVTSPEELAI | 531 | O75564 | |
| TDVDLDGRPEVLVAT | 316 | Q9Y664 | |
| LIAEQPVSEVETRVI | 71 | O75380 | |
| EQIVIGRLDEDIILP | 36 | Q9UM44 | |
| VALRGEDVPLTEQTV | 146 | P61923 | |
| EVEEGELEIVPVRRS | 41 | Q53F19 | |
| EAIGNEVTRLVRLDP | 1566 | P42356 | |
| EGTEVVALLESERPE | 76 | Q9NP85 | |
| LVEELRLNPDGVETV | 766 | O94854 | |
| GQVLDVVERLVTPGE | 576 | P55268 | |
| VSGTGLRELPEEIEE | 51 | A6NIK2 | |
| TGVERIELPQFSIVE | 201 | P28472 | |
| GRQEEIPVVIAASED | 61 | Q68CQ7 | |
| VRETESQLLPDVGAI | 56 | Q9Y3B2 | |
| IIIEDLLEATRSPEV | 2151 | Q92616 | |
| REPGDLAERVEVVAL | 226 | Q96N21 | |
| PLEEVTVAEVLAARG | 101 | P15289 | |
| GTEVTLAEVPLLDEV | 501 | Q16643 | |
| RIVPLENGEIVVSLV | 221 | O15230 | |
| TRVVQVLATDLDEGP | 261 | Q9UN70 | |
| IVIATPGRLIDVLEN | 521 | Q9BUQ8 | |
| SILGELSEPLREEII | 401 | Q9P1Z3 | |
| ITLDPLEIVGGEIRA | 3586 | Q9Y4D8 | |
| QEGVELVDVRVPLFI | 936 | P16144 | |
| TGIVVEDNTEIILDP | 316 | Q9Y3Q4 | |
| EVIVAEGESLLLSVP | 4856 | Q9UPN3 | |
| PVIRQGVLEVLSEVE | 41 | O75161 | |
| PSIEGPEREVIVETI | 3151 | Q96RW7 | |
| EIPSDVSVLLGENVE | 3251 | Q96RW7 | |
| VGLELPVQIEEVIES | 731 | Q86Y26 | |
| EAVEITEDSLPGVIV | 2351 | Q6V1P9 | |
| LRVRPISVAELEEGA | 16 | Q2TAC6 | |
| VIEVIPFLVLAVGVD | 686 | O15118 | |
| EPEVTIVRGLVDAEV | 4156 | Q5VST9 | |
| VTERVQPLEVALETL | 81 | Q8IZE3 | |
| VPEEGTVGREIALID | 356 | Q9Y5H0 | |
| EDLELLPGDVLVVSR | 21 | O00459 | |
| LEEGVLNPETTVVAI | 476 | O43252 | |
| EIAIELRSSVGAPVE | 401 | Q92900 | |
| VPAEVTVILLDIEGT | 6 | Q9UHY7 | |
| TAIAPLDGEELIVEV | 76 | P10398 | |
| EAIDPALEGRIVLTV | 651 | Q9BYE9 | |
| LTEEESAPIGIRVLD | 1096 | O75054 | |
| EDIIEPRTLNEITTV | 2066 | Q4AC94 | |
| VVSLILSDVVGDPVE | 236 | Q8IVS8 | |
| ITVAELREAVPALLG | 226 | P57796 | |
| EVEIPARELRNVGVE | 256 | Q99715 | |
| RGVGPELEVQEDLLT | 196 | Q7L775 | |
| VEVPEDVAIGTTIQI | 396 | Q9HBT6 | |
| ALIEFLLEGTPEIRE | 666 | Q96JB2 | |
| RVEEGVPQVLVLISA | 341 | P12111 | |
| RIILAPINADITVGE | 506 | Q12860 | |
| LDEVGISRIEAVLPQ | 431 | Q53R41 | |
| NIPTLEGRILVELDE | 51 | Q15398 | |
| VVQREDVETGLDPLS | 1191 | Q5VZ89 | |
| RPENEEDILVVTTQG | 126 | Q13137 | |
| LVGELLTSQPEVDER | 1061 | Q6IQ26 | |
| RNIPRGSDIIVDLEV | 126 | Q9UBS4 | |
| LVNEERTLEVEIEPG | 201 | Q9UBS4 | |
| VEAEDPGRLAVEALV | 186 | Q92839 | |
| IDVSDVIRLVQDTPE | 36 | O15068 | |
| PDALRVRSGDVVELV | 1071 | O15068 | |
| AIVVSDRDGVPVIKV | 21 | Q9UHA4 | |
| PITDVAVIARALGEE | 46 | O75064 | |
| GILSPVQEVRAAAEE | 31 | Q96P70 | |
| EVVLLDAPVGLVARL | 141 | P19235 | |
| RVDTVRVVEGPREVE | 326 | Q63ZY3 | |
| GTAIIQLEEREVLPV | 481 | Q96J84 | |
| QLEEREVLPVGIIAG | 486 | Q96J84 | |
| VGILAEDRPSEQLVE | 931 | Q8WUI4 | |
| VAARGLDIPEVDLVI | 496 | Q9NR30 | |
| PIRPIEESDQGTEVI | 431 | Q9UJW0 | |
| VLEGVDVLLTQEVRP | 81 | Q5VWM4 | |
| GVAESIRETEVIDPQ | 16 | P31431 | |
| IRETEVIDPQDLLEG | 21 | P31431 | |
| GARVIITEIDPINAL | 236 | P23526 | |
| EIPGAFIALITIDRV | 386 | O15245 | |
| EVTEEELPEGTVRLG | 126 | Q99445 | |
| VLTPTRELALQVEGE | 321 | Q9NXZ2 | |
| VGLPAEDVTLIIAVD | 426 | P43005 | |
| SIEAGVTAIRPEDLE | 776 | Q96JN8 | |
| RTPQEAITDGLEIVV | 26 | Q99496 | |
| KRIEIAEVVPTEGLV | 606 | Q6PJW8 | |
| ALDLEERATVTPGVE | 941 | Q96NU0 | |
| VRPITERSLLQGDEI | 76 | Q9UHY8 | |
| ELVVGRIRNTPETDE | 1196 | Q12756 | |
| VPVEQFRIEEIAEGR | 791 | Q13615 | |
| SEIIAAILIGDPTVR | 291 | Q9UKG9 | |
| EVIVLSRLDPGDLSV | 546 | Q68BL7 | |
| TGDVPLIRIEEDTGE | 101 | Q9BZA8 | |
| EVVEEPRVRLGTEGV | 31 | Q9BZF2 | |
| IVLVRTEDVAPADIV | 1276 | Q6ZRI0 | |
| IVEGIIRSPDLVRVQ | 96 | O15397 | |
| VDTEGPALVEIDRSV | 556 | Q96PC5 | |
| LDGRELSAPVIVDID | 356 | Q9GZY0 | |
| IPEDILGEIAVSIVR | 161 | P46734 | |
| ERREVVGTPSFLEEV | 186 | Q693B1 | |
| VDPELVVTVLGDLEQ | 231 | Q8NEY1 | |
| QIDRETGIGDVPLVI | 1611 | Q8NEY1 | |
| EVPDVRIVTEVIEVR | 256 | Q8N9W8 | |
| RTPGSLIAEIILVDD | 166 | Q49A17 | |
| ESAVIVANPREEIIV | 311 | Q9NQC3 | |
| VGQAGPEITDELVRV | 2166 | Q5T011 | |
| ERIRGVLSVITEELP | 426 | Q9NXH9 | |
| VLVGEVDFLERPIIA | 431 | Q9Y6M7 | |
| VVLPELIELSRDEGS | 251 | Q6NUP7 | |
| SEEVVLTPAELIERL | 16 | Q9BRT9 | |
| EVVESSIPSVGLVEE | 6706 | Q8NF91 | |
| LPSVSLVEETEERLV | 4861 | Q8WXH0 | |
| VVREETLELGLEPGL | 186 | Q9NX61 | |
| GVVTIEQIVDTLPDR | 581 | P09917 | |
| PDAGVIIEELSQRIA | 276 | Q7L592 | |
| VPIQGITLEEVSEII | 871 | Q14934 | |
| LSRELVEVVEPEVLQ | 986 | A0A087WUL8 | |
| VLARLIGEPDLVVSV | 206 | Q9H9A7 | |
| LTNRVEDPIRVGEIA | 56 | P0C7V7 | |
| EDPIRVGEIAVLRIE | 61 | P0C7V7 | |
| GPLDETQIATILREI | 126 | Q9Y6E0 | |
| RTTVLIEQDPGTLED | 46 | Q14872 | |
| SEAGIELIIEDDIRP | 551 | P10244 | |
| GLPDLVAVLTRVIEE | 2686 | P58107 | |
| GLPDLVAVLTRVIEE | 3751 | P58107 | |
| VTELDVVLTAGDIPV | 571 | Q5JRX3 | |
| VRDGLDLTDIVPRET | 771 | Q13635 | |
| PGELAELVRSVRLVE | 256 | Q9NR45 | |
| IVSRPEELREDDVGT | 331 | P49368 | |
| DPDVVALVVRDGELA | 106 | A0A087WV53 | |
| DDEPVIRGFIIAEIV | 556 | P49221 | |
| RALFVDLEPTVIDGI | 71 | A6NHL2 | |
| SLLEVTVANPVEGEL | 366 | Q8NEZ3 | |
| VLQGEEPIEIRSGVS | 3546 | P08F94 | |
| SNVLVGEVDILDRPI | 301 | Q2Y0W8 | |
| LEVELTPQGTLAERI | 131 | P55809 | |
| EGSLEPQIEDLISRI | 41 | A8MT33 | |
| PEVLGQRSTDVVDLE | 396 | Q9NRP7 | |
| IITDVIGNPEEERRA | 481 | Q92925 | |
| VRAIPVDIGFSIEEL | 806 | Q66K14 | |
| IRTIAIIAEGIPEAL | 591 | P53396 | |
| VPRSFDELGEIIQSV | 786 | P53396 | |
| TLADIERIAPLEEGT | 286 | Q9UJS0 | |
| LDIPGLEVAVVTTER | 41 | Q96CD2 | |
| VGENEETVIIGLRLE | 66 | Q9H8M5 | |
| TPELERQGVLLVEFE | 106 | Q9NQ32 | |
| EARLTVVPVSEEEVR | 226 | P11086 | |
| VVPVSEEEVREALVR | 231 | P11086 | |
| SIPDLAVDVEQVIGL | 501 | Q9Y4G8 | |
| VLEGVDVLLTQEVRP | 81 | Q5VXH5 | |
| EEVSRTLGLVPRDQE | 151 | P10074 | |
| REFSVPEIIAIAVVG | 471 | P17643 | |
| ISISQDIPVEGEITI | 26 | Q96EC8 | |
| VEIPELEEAEGNITR | 116 | Q96BF3 | |
| EVLEQIPGIAEILLE | 196 | Q96PX8 | |
| LQELESEPVIQVTVG | 606 | Q9Y6Q2 | |
| EVERSGTLALVEPLV | 286 | Q6SZW1 | |
| RGEIIDPFVEVEIIG | 781 | O75038 | |
| QEALEAVPRGEIEVV | 776 | Q15269 | |
| AEVRPGVLELLAVVQ | 76 | Q6ZMY3 | |
| VTVPQLELDVGLSRE | 1216 | Q9BXM0 | |
| EEIRVVVRPVEDGEI | 76 | Q5T0D9 | |
| EVVTEDLPQLGDLAV | 1341 | P24821 | |
| ERLGEELVAIVESPL | 11 | Q8IZM8 | |
| PDVRTVELISTGDEE | 486 | Q6P2S7 | |
| GPLVVALQVRVVEAE | 846 | Q9H254 | |
| NRVEDPIRVGEIVVF | 71 | P67812 | |
| EIVVFRIEGREIPIV | 81 | P67812 | |
| QLLGVEEVTDPDVVL | 81 | Q96JH7 | |
| VLGTPVETIELTEDR | 501 | P27708 | |
| SGGPVVVLVQLEREE | 2031 | O75643 | |
| VVLVQLEREEEVTGP | 2036 | O75643 | |
| LEREEEVTGPVIAPL | 2041 | O75643 | |
| AIVGRLTEVLEEPEA | 436 | Q96NZ8 | |
| GVRIEDDVVVTQDSP | 471 | Q9NQH7 | |
| PVVIENVLEGDELRT | 186 | Q9HD40 | |
| IPREVFENSGILVTD | 2396 | Q5VWN6 | |
| EIVTDDGENLRPIVI | 236 | Q9C0D7 | |
| PLVAETRLGEAEVAL | 586 | Q86VR7 | |
| ALEAVVPAVRGEDVQ | 606 | Q5QJ38 | |
| VEELSEPVLGDVRES | 136 | Q01831 | |
| IIDGVPVEITEKETR | 736 | Q15063 | |
| SVDVRIPEQIIVVDS | 1581 | Q12789 | |
| DVVTEGVIVPEAVLE | 81 | Q9Y462 | |
| GVIVPEAVLEADVAI | 86 | Q9Y462 | |
| IEGSREDIVVPVYLR | 581 | P51784 | |
| GSEIDIRIRVPSIEF | 356 | P48595 | |
| GLPESEFLIVLRDVV | 106 | Q9UHD2 | |
| REQQPESGEEAVVLV | 111 | O60304 | |
| ELRLTFPVRDGVVLE | 561 | Q9ULJ6 | |
| EDIIRLVGELVSIVG | 381 | Q9NQA5 | |
| DIILNPETIVELIGF | 1111 | Q5THJ4 | |
| PDTEQELEVLVRLEG | 3821 | Q5THJ4 | |
| RSGVEVLFNELEIPV | 661 | O43795 | |
| LTIIDLPGITRVAVD | 221 | P20592 | |
| GIVVVPRDAADTDRI | 226 | Q9BZQ4 |